So I got this email from a reader after the consumer VC recovery post I shared last week:

“David, I read the last breakdown you made on Huel after their acquisition by Danone, and now this one. The Creators Blueprint is a newsletter I now often anticipate. But I have a question based on this particular post. If functional beverages are now proven and crowded, what specific early signals separate the next Poppi from the dozens of well-funded brands that will plateau at $5–10M revenue?”

This is THE question.

Because you’re right, functional beverages are now proven. Which means everyone and their mother is launching one.

In the last 18 months alone:

• 50+ prebiotic soda brands launched

• 30+ adaptogenic drinks

• 20+ electrolyte beverages with “functional benefits”

• Maybe 2-3 will actually matter

The hit rate in functional beverages is brutal:

• 100 brands launch

• 90 plateau at $1-5M revenue (lifestyle businesses or failures)

• 8 get to $10-30M revenue (solid but not venture-scale)

• 2 break $100M+ revenue (Poppi, Olipop territory)

• 0.5 exit for $1B+ (Poppi is the outlier, not the norm)

So the question becomes:

How do you spot the 0.5% winner when it’s still at $5M revenue before Pepsi writes the $2B check?

I’ve spent the last few days thinking about this (and pulling data on Poppi’s early years vs. the brands that died). Let me show you the seven early signals that separate billion-dollar exits from brands that plateau and why most investors/operators miss them.

Signal #1: Founder Has “Category Insider + Outsider” DNA (Not Just One)

The pattern everyone misses:

The best functional beverage founders aren’t beverage experts. But they’re not total outsiders either.

They’re hybrids.

Poppi (Allison Ellsworth), The Perfect Hybrid:

Insider knowledge:

• Husband Stephen Ellsworth worked in grocery (HEB, regional chain)

• Understood retail dynamics, slotting fees, distributor relationships

• Knew how to get into stores (critical for beverage scale)

Outsider perspective:

• Allison was a blogger/influencer (not beverage industry)

• Saw trends from consumer side (what people actually wanted)

• Didn’t have “industry blinders” (wasn’t stuck in “this is how beverages work”)

The combination:

• Insider = Could navigate retail (distribution is the moat in beverages)

• Outsider = Saw prebiotic trend before beverage industry did

• Hybrid = Could build category-defining brand AND get it into 50K stores

For comparison, brands that failed:

Pure insiders (beverage industry veterans):

• Launch traditional beverage with “functional twist”

• Can get distribution (they have relationships)

• But positioning is boring (sounds like every other beverage)

• Plateau at $10-20M (distributors carry it but consumers don’t care)

Pure outsiders (influencers, wellness founders):

• Launch innovative positioning (great branding, unique angle)

• Can’t get distribution (don’t know retail)

• DTC-only, can’t scale past $5M

• Plateau at $3-8M (great product, no path to scale)

The early signal: When evaluating a functional beverage brand at $2-5M revenue, ask:

1. Does the founder understand retail distribution? (Insider knowledge)

   • Do they know what slotting fees are?

   • Do they have existing distributor relationships?

   • Have they worked in grocery/beverage before?

2. Does the founder see consumer trends before the industry? (Outsider perspective)

   • Are they plugged into wellness/health communities?

   • Do they have audience/following outside of beverage world?

   • Are they creating new category or just copying existing?

If both = yes, that’s Signal #1. If only one = plateau risk.

Signal #2: They Cracked “Occasion-Based Positioning” (Not Benefit-Based)

This is the most underrated signal.

Most functional beverage brands position on benefits:

• “Supports gut health”

• “Boosts immunity”

• “Enhances focus”

Winners position on occasions:

• “Instead of soda with lunch”

• “After morning workout”

• “3pm desk slump replacement”

Why this matters:

Benefit positioning = narrow TAM

• Only people who care about gut health buy it

• Requires consumer education (expensive)

• TAM: 5-10M health-conscious consumers

Occasion positioning = massive TAM

• Everyone eats lunch, works out, has afternoon slump

• Replaces existing behavior (easier adoption)

• TAM: 50-100M+ people

Poppi’s genius:

Early Poppi positioning (2018-2020): “Prebiotic soda for gut health”

Revenue: Struggled to break $5M

Why?

• Only appealed to people who (a) knew what prebiotics were AND (b) cared about gut health

• Required education (”What’s a prebiotic?” “Why do I need this?”)

• Narrow positioning = slow growth

Revised Poppi positioning (2020-2022): “Soda that’s good for you”

Occasion = soda replacement

• Lunch with burger

• Movie night snack

• Afternoon refreshment

• Any time you’d drink Coke, drink Poppi instead

Revenue: $5M → $50M → $200M → $400M

The shift:

• From “prebiotic gut health drink” (benefit)

• To “healthy soda” (occasion replacement)

• Unlocked 20x larger TAM

For comparison, brands that plateau:

Culture Pop:

• Positioning: “Probiotic soda for digestive wellness”

• Occasion: Unclear (when do you drink this?)

• Revenue: Stuck at $8-12M

Health-Ade Kombucha:

• Positioning: “Fermented tea for gut health”

• Occasion: Health ritual (very narrow)

• Revenue: $100M+ but took 10+ years (slow growth, narrow positioning)

Olipop (the other winner):

• Positioning: “Soda with digestive health benefits”

• Occasion: Soda replacement (lunch, dinner, snack)

• Revenue: $500M+ in 6 years (occasion-based positioning = fast growth)

The early signal:

When a brand is at $2-5M revenue, ask: “When do people drink this?”

If the answer is:

• “When they want to support their gut health” → Plateau risk

• “When they’d normally drink soda” → Winner potential

Occasion-based positioning = 5-10x larger TAM = venture-scale outcome possible.

Benefit-based positioning = niche forever.

Signal #3: DSD Distribution BEFORE DTC Scale (Counterintuitive but Critical)

Here’s where everyone gets this backwards:

Most beverage founders think:

1. Build brand via DTC ($5-10M revenue)

2. Prove demand

3. Then approach distributors

4. Scale through retail

This is wrong for beverages.

Winners do:

1. Get into local/regional DSD (Direct Store Delivery) early

2. Prove retail velocity (units per store per week)

3. Use retail traction to raise VC

4. Then scale DTC + national retail simultaneously

Why DSD-first matters:

Beverages are different from other CPG:

• Heavy (shipping costs kill DTC margins)

• Low AOV ($30-40 for 12-pack, $5-7 shipping = terrible economics)

• Impulse purchase (people buy in-store, not online)

• DTC doesn’t work for beverages the way it works for beauty/supplements

Poppi’s actual path (this is public):

2018-2019: Texas regional DSD

• Started in Dallas/Fort Worth

• Got picked up by KeHE (natural distributor)

• Proved: 3-5 units per store per week velocity

• Revenue: $1-3M (mostly Texas retail)

2019: Shark Tank

• Rohan Oza invested $400K for 25% (appeared to be terrible deal)

• But Rohan = beverage distribution god (scaled Vitaminwater, Bai, Smartwater)

• Rohan opened: Big Geyser (NYC DSD), UNFI (national), DPI (Southwest)

• Revenue: $3M → $10M (distribution explosion)

2020-2021: National DSD buildout

• Used Shark Tank + early retail traction to raise VC

• CAVU invested (beverage-focused PE)

• Expanded DSD to 20,000+ stores

• Revenue: $10M → $50M → $150M

2022-2023: DTC as complement (not foundation)

• DTC grew BUT only represents 15-20% of revenue

• Retail is 80-85% of revenue

• DTC exists to capture superfans, not build the business

For comparison — brands that plateau:

Pure DTC beverage brands:

• Build to $3-5M revenue DTC

• Can’t get retail distribution (don’t know DSD)

• Shipping costs destroy margins

• Stuck at $5-8M (DTC ceiling for heavy/low-AOV products)

Example: Dozens of adaptogen/nootropic drinks

• Great branding, strong DTC

• $3-8M revenue

• Can’t crack retail (no DSD relationships)

• Plateau forever

The counterintuitive truth:

You can have the best brand in the world. If you can’t get into 10,000+ doors via DSD, you’ll never break $20M revenue.

The early signal:

When a functional beverage brand is at $2-5M revenue, ask: “What percentage is retail vs. DTC?”

If the answer is:

• “95% DTC, we’ll do retail later” → Plateau risk (they don’t understand beverage economics)

• “60% retail via regional DSD, 40% DTC” → Winner potential (they understand distribution is the game)

Bonus signal:

• “We’re working with Big Geyser / KeHE / UNFI / DPI” → These are the DSD networks that scaled Vitaminwater, Poppi, Olipop

• “We’re doing our own distribution” → They’re about to learn a very expensive lesson

Signal #4: They Have “Influencer-Proof” Growth (Not Influencer-Dependent)

This one’s sneaky but absolutely critical.

Here’s the test:

Month 1-6 after they stop spending on influencer marketing:

• Does revenue stay flat/grow? (Winner)

• Does revenue drop 30%+? (Plateau brand)

Why this matters:

Influencer-dependent brands:

• Revenue = function of influencer spend

• Stop spending → revenue craters

• These are marketing machines, not brands

Influencer-proof brands:

• Revenue = function of word-of-mouth + retail velocity

• Stop spending → revenue stays flat or grows slightly slower

• These are real brands with organic demand

Poppi’s trajectory:

2020-2021: Heavy influencer spend

• TikTok creators, Instagram wellness influencers

• Paid partnerships, gifting campaigns

• This got initial trial

2022-2023: Pulled back influencer spend

• Focused budget on retail placement, in-store promos

• Influencer spend dropped 40%+ (estimated)

• Revenue still grew 100%+ (organic demand kicked in)

Why?

• Retail velocity drove reorders (people bought in-store without influencer push)

• Word-of-mouth from trial (people told friends)

• Product sold itself after initial awareness

For comparison, brands that plateau:

Countless “viral” beverage brands:

• Launch with massive influencer push

• Hit $5M revenue in Year 1 (looks amazing)

• Year 2: Maintain spend to maintain revenue

• Year 3: Influencer costs up, revenue flat

• Stuck at $5-8M (can’t scale profitably)

The pattern:

• Revenue is rented (via influencer spend)

• Not owned (via organic demand)

• As soon as spend stops, revenue collapses

The early signal:

When a brand is at $2-5M revenue, ask: “What happens if they cut influencer spend by 50% next quarter?”

If the answer is:

• “Revenue would drop 40%+” → Influencer-dependent (plateau risk)

• “Revenue would stay flat or drop <20%” → Influencer-proof (winner potential)

How to test this from outside:

Look at their growth trajectory:

• Steady linear growth (10-20% MoM for 12+ months) = organic demand kicking in

• Spiky growth (50% one month, flat next month, 30% next) = paid marketing driving everything

Poppi/Olipop: Steady linear growth (organic demand)

Most $5M plateau brands: Spiky growth (paid marketing)

Signal #5: Retail Velocity Beats Category Average by 2x+ (The Only Metric That Matters)

Here’s the dirty secret of beverage distribution:

Getting into stores is easy. Staying in stores is hard.

The metric that determines everything: Units per store per week (velocity)

Category benchmarks (carbonated soft drinks):

• Below 1 unit/store/week = will be delisted within 6 months

• 1-2 units/store/week = marginal, might survive

• 3-5 units/store/week = solid performer

• 6+ units/store/week = hero product, gets expanded distribution

Poppi’s early velocity (2019-2020 in Texas):

• Whole Foods: 4-6 units/store/week

• Target: 3-4 units/store/week

• Average: 4-5 units/store/week (2x category average)

Why this mattered:

High velocity =

• Retailers reorder more frequently (more revenue)

• Retailers expand shelf space (more facings)

• Retailers expand to more stores (regional → national)

• Velocity creates flywheel

Low velocity =

• Retailers question value of shelf space

• Brand gets delisted

• Death spiral

For comparison, brands that plateau:

Most functional sodas:

• Launch into 500-1,000 stores

• Velocity: 1-2 units/store/week (below threshold)

• Get delisted within 12 months

• Revenue: $3M → $5M → back to $2M (distribution loss)

The early signal:

When a brand is at $2-5M revenue, ask: “What’s their velocity in existing stores?”

If the answer is:

• Below 2 units/store/week → Will plateau or die (poor product-market fit)

• 3-5 units/store/week → Solid, could scale (good product-market fit)

• 6+ units/store/week → Winner potential (excellent product-market fit)

How to find this if you’re not an insider:

• Ask the founder directly (”What’s your velocity at Whole Foods?”)

• Check secondary data (some distributors share this)

• Watch for store expansion (if a brand goes from 100 Whole Foods → 400 Whole Foods in 6 months, velocity is strong)

Poppi went from:

• 500 stores (2019)

• 5,000 stores (2020)

• 15,000 stores (2021)

• 30,000 stores (2022)

• 50,000+ stores (2024)

That expansion = proof of velocity.

If velocity was weak, they’d have been delisted, not expanded.

Signal #6: They Solve “The Fridge Problem” (Repeat Purchase Behavior)

This is the unlock everyone misses.

The Fridge Problem:

You buy a functional beverage at Whole Foods. You drink it. You like it.

Question: Do you go back and buy a 12-pack? Or do you forget about it and buy regular soda next time?

Winners solve this.

Losers don’t.

How to test if a brand has solved The Fridge Problem:

Look at DTC subscription rate:

• Below 15% of DTC = people forget to reorder (Fridge Problem unsolved)

• 15-30% of DTC = decent repeat (Fridge Problem partially solved)

• 30%+ of DTC = strong repeat (Fridge Problem solved)

Poppi/Olipop:

• DTC subscription rate: 35-40% (estimated from interviews)

• Retail repeat rate: 50-60% (people come back within 30 days)

• Fridge Problem: Solved

Why they solved it:

1. Taste is good enough to replace soda:

• Not “healthy but tolerable”

• Actually “delicious AND healthy”

• People choose it over Coke, not just tolerate it

2. Variety pack strategy:

• 12-pack with 4 flavors (3 of each)

• Creates “collection” behavior

• People want to try all flavors → repeat purchase

3. Fridge-stocking behavior:

• Packaging encourages buying 12-packs

• People put in fridge, drink over week

• Becomes part of routine

For comparison, brands that plateau:

Most functional beverages:

• Taste is “fine” (not crave-worthy)

• People try once, don’t repeat

• Fridge Problem: Unsolved

Example: Hundreds of kombucha brands

• Trial rate: High (people curious)

• Repeat rate: Low (taste is acquired, not crave-worthy)

• Stuck at $3-8M (trial without repeat = no scale)

The early signal:

When a brand is at $2-5M revenue, ask:

“What percentage of customers who try it buy again within 30 days?”

If the answer is:

• Below 30% → Fridge Problem unsolved (plateau risk)

• 30-50% → Fridge Problem partially solved (could scale with work)

• 50%+ → Fridge Problem solved (winner potential)

How to test this from outside:

• Check DTC site: Do they offer subscriptions? What’s the % discount? (If 20%+ discount, they’re desperate for repeat)

• Check reviews: Do people say “I’m addicted” or “I buy this weekly”? (Signals repeat behavior)

• Check Amazon: Look at number of reviews per year (high review velocity = high repeat purchase)

Poppi on Amazon:

• 10,000+ reviews

• Most say “I buy monthly” or “I’m hooked”

• Fridge Problem: Solved

Signal #7: Founder Has “Irrational Persistence” on Single Bet (Not Pivoting Every 6 Months)

The final signal is psychological.

Most beverage founders:

• Launch prebiotic soda

• Doesn’t work immediately

• Pivot to adaptogen drink

• That doesn’t work

• Pivot to electrolyte beverage

• Never commit long enough to any one thing

Winners:

• Launch prebiotic soda

• Doesn’t work immediately

• Keep iterating on prebiotic soda for 3-5 years

• Figure out the formula, positioning, distribution

• Finally break through

Poppi’s timeline:

2016-2018: Mother Beverage (original name)

• Sold at Dallas farmers markets

• Revenue: $100K/year

• Most founders would have quit

2018: Rebranded to Poppi, appeared on Shark Tank

• Still only $1M revenue

• Still only Texas regional

• Most founders would have pivoted to “the next trend”

2019-2021: Kept iterating on distribution, positioning

• Same product (prebiotic soda)

• Just better distribution, better positioning

• Revenue: $1M → $10M → $50M → $150M

The persistence:

Allison Ellsworth spent 5 years selling the same basic product (prebiotic soda) before it broke through.

Most founders give up in Year 2.

For comparison — brands that plateau:

Founders who pivot:

• Year 1: Prebiotic soda

• Year 2: Not working, pivot to adaptogen

• Year 3: Not working, pivot to nootropic

• Never commit to one thing long enough to figure it out

The pattern:

• Serial pivoting = never build brand equity in one category

• Never achieve distribution depth in one category

• Plateau at $3-5M (good at launching, bad at scaling)

The early signal:

When evaluating a founder at $2-5M revenue, ask: “How long have they been working on this specific product/category?”

If the answer is:

• Less than 2 years → Too early to tell, might pivot

• 2-4 years → Committed, iterating

• 4+ years → Irrational persistence (winner trait)

And then ask:

“Have they pivoted categories in the last 2 years?”

If yes → Pivot risk (might abandon this too)

If no → Committed (will see it through)

Why irrational persistence matters:

Beverages take 4-7 years to hit scale:

• Year 1-2: Build product, get initial distribution

• Year 2-3: Prove velocity, expand regionally

• Year 3-5: Raise VC, go national

• Year 5-7: Hit $100M+ revenue, get acquired

Most founders quit in Year 2-3 (before the compounding kicks in)

Winners stay through Year 5-7 (irrational persistence pays off)

The Checklist: How to Spot the Next Poppi at $5M Revenue

Okay, so you’ve read all seven signals. Here’s how to actually use them:

When you see a functional beverage brand at $2-5M revenue, run this checklist:

Signal #1: Founder DNA

• Founder has insider knowledge (retail/distribution/beverage experience)

• Founder has outsider perspective (not stuck in industry norms)

• Score: 1 point if both, 0 if only one

Signal #2: Occasion-Based Positioning

• Brand positions on occasion (”instead of soda”) not benefit (”supports gut health”)

• Occasion is daily/frequent (lunch, workout, afternoon slump)

• Score: 1 point if yes to both, 0 if benefit-based

Signal #3: DSD Distribution First

• 50%+ of revenue is retail (not DTC)

• Working with major DSD networks (Big Geyser, KeHE, UNFI, DPI)

• Score: 1 point if yes to both, 0 if DTC-first

Signal #4: Influencer-Proof Growth

• Revenue growth is steady/linear (not spiky)

• Could sustain 50% influencer cut without revenue collapse

• Score: 1 point if yes to both, 0 if influencer-dependent

Signal #5: Retail Velocity

• Velocity is 3+ units/store/week in existing stores

• Store count is expanding (retailers adding doors)

• Score: 1 point if yes to both, 0 if velocity weak

Signal #6: Fridge Problem Solved

• 50%+ of customers repurchase within 30 days

• DTC subscription rate is 30%+ (if applicable)

• Score: 1 point if yes to one, 0 if neither

Signal #7: Irrational Persistence

• Founder has worked on this specific product/category for 3+ years

• No major category pivots in last 2 years

• Score: 1 point if yes to both, 0 if pivot risk

Total Score:

0-2 points: Plateau brand (will likely stay at $5-20M revenue)

3-4 points: Solid brand (could reach $50-100M revenue, might get acquired)

5-6 points: Winner potential (could reach $200M+ revenue, strategic interest)

7 points: Rare (next Poppi/Olipop, track closely)

The Brands to Watch Right Now (Applying the Framework)

Let me run this framework on a few current functional beverage brands to show you how it works:

Brand #1: Culture Pop (Probiotic Soda)

Signal #1 - Founder DNA:

• Founders are wellness entrepreneurs (outsider perspective ✓)

• No deep retail/distribution background (insider knowledge ✗)

• Score: 0

Signal #2 - Occasion Positioning:

• Positioned on benefit (”probiotic for gut health”)

• Not clear occasion replacement

• Score: 0

Signal #3 - DSD Distribution:

• In 2,000+ stores via KeHE

• Retail-focused model

• Score: 1

Signal #4 - Influencer-Proof:

• Hard to assess from outside, but growth seems steady

• Score: 0.5 (uncertain)

Signal #5 - Retail Velocity:

• Not expanding rapidly (stuck at ~2,000 stores for 18 months)

• Suggests velocity is marginal

• Score: 0

Signal #6 - Fridge Problem:

• Reviews suggest trial but not “I’m addicted” repeat behavior

• Score: 0

Signal #7 - Persistence:

• Founded 2020, still working on same product 4+ years later

• Score: 1

Total: 2.5/7 → Plateau brand (likely stays at $10-20M)

Brand #2: Olipop (Prebiotic Soda): For Comparison

Signal #1: Founder DNA:

• Ben Goodwin (founder) worked in beverage industry (Obi Probiotic Soda)

• But brought outsider nutrition science perspective

• Score: 1

Signal #2: Occasion Positioning:

• “Soda alternative” (clear occasion = any time you’d drink soda)

• Score: 1

Signal #3: DSD Distribution:

• 30,000+ stores via major DSD networks

• Score: 1

Signal #4: Influencer-Proof:

• Steady growth even as influencer spend plateaued

• Score: 1

Signal #5: Retail Velocity:

• Rapid expansion (proof of velocity)

• Score: 1

Signal #6: Fridge Problem:

• High Amazon review volume, people say “weekly purchase”

• Score: 1

Signal #7 - Persistence:

• Ben spent 7+ years building this (previous company Obi failed, kept iterating)

• Score: 1

Total: 7/7 → Winner (already at $500M+ revenue, validates framework)

Brand #3: [Redacted New Launch]: Testing the Framework

I won’t name this brand publicly because they’re only at $3M revenue, but:

Signal #1 - Founder DNA:

• Founder worked at KeHE (distributor) = insider

• Came from wellness influencer world = outsider

• Score: 1

Signal #2 - Occasion Positioning:

• Positioned as “coffee alternative for afternoon energy”

• Clear occasion (3pm slump)

• Score: 1

Signal #3 - DSD Distribution:

• Already in 800 stores via KeHE (Year 1!)

• 60% retail, 40% DTC

• Score: 1

Signal #4 - Influencer-Proof:

• Too early to tell (only 12 months in)

• Score: 0 (too early)

Signal #5 - Retail Velocity:

• Expanding from 800 → 2,000 stores in next 6 months

• Retailers asking for more (velocity signal)

• Score: 1

Signal #6 - Fridge Problem:

• DTC subscription rate: 38%

• Score: 1

Signal #7 - Persistence:

• Only 1 year in (too early to assess)

• Score: 0 (too early)

Total: 5/7 (unknown on 2) → Watch closely (winner potential if persistence holds)

The Uncomfortable Truth About Picking Winners

Here’s what I’ve learned after tracking 100+ functional beverage launches:

The hit rate is worse than you think:

Out of 100 functional beverage brands that launch:

• 90 will die or plateau at $1-5M (90%)

• 8 will reach $10-50M (8%)

• 1.5 will reach $100M+ (1.5%)

• 0.5 will exit for $500M+ (0.5%)

That’s a 0.5% hit rate for venture-scale outcomes.

Even with the seven-signal framework:

• Brands scoring 5-6/7 have maybe 10-15% chance of $100M+ outcome

• Brands scoring 7/7 have maybe 30-40% chance

• There’s still massive luck involved (timing, distribution breaks, viral moments)

The honest answer to “how do I spot the next Poppi?”

You probably can’t with certainty.

But you can improve your odds from 0.5% to 10-15% by focusing on brands that score 5+ on the seven signals.

And if you find a 7/7 brand at $5M revenue?

Back it heavily.

Because even though it’s not guaranteed, those are lottery ticket odds worth taking.

What I’d Do If I Were Deploying Capital in Functional Beverages Right Now

If I had $5M to invest in functional beverages:

I would NOT:

• Spray $250K across 20 brands (venture spray-and-pray)

• Wait for brands to hit $50M revenue (too late, valuation too high)

• Only invest in “proven” brands (Poppi is already $2B, you missed it)

I WOULD:

• Find 3-5 brands at $2-8M revenue scoring 5+/7 on framework

• Write $500K-1M checks at $10-20M valuations (15-25% ownership)

• Help them with distribution (intro to DSD networks)

• Accept that 2-3 will fail, 1-2 will return 5-10x, 0-1 will return 50-100x

The specific brands I’d target:

Criteria:

1. Score 5+/7 on framework

2. Revenue $2-8M (early enough for ownership, late enough for signal)

3. Raising seed/Series A ($2-5M round at $15-30M valuation)

4. Founder has beverage/distribution background + outsider perspective

5. Already in 1,000+ stores via DSD (proof they understand distribution)

Current brands that fit (as of April 2026):

• 2-3 exist (won’t name publicly, but if you’re serious about deploying capital, DM me)

The Final Answer to Your Question

You asked:

“If functional beverages are now proven and crowded, what specific early signals separate the next Poppi from the dozens of well-funded brands that will plateau at $5–10M revenue?”

The seven signals:

1. Founder has insider + outsider DNA (hybrid, not pure)

2. Occasion-based positioning (replaces soda, not “supports gut health”)

3. DSD distribution first (retail 50%+, not DTC-first)

4. Influencer-proof growth (organic demand, not paid marketing machine)

5. Retail velocity 3+ units/store/week (proof of product-market fit)

6. Fridge Problem solved (50%+ repeat purchase within 30 days)

7. Irrational persistence (4+ years on same product, no pivots)

Brands scoring 5+/7 have 10-15% chance of $100M+ outcome.

Brands scoring 7/7 have 30-40% chance of $100M+ outcome.

Brands scoring 0-4/7 will plateau at $5-20M.

But even with perfect signal detection, you’re still betting on a 10-40% hit rate.

Functional beverages are crowded because they’re proven.

And when a category is proven, capital floods in, competition intensifies, and hit rates compress.

The real alpha isn’t just finding the right signals.

It’s finding them BEFORE everyone else realizes these are the signals that matter.

Which is why I’m publishing this publicly.

Because by the time everyone’s using this framework, the next meta will have emerged.

And I’ll be writing about that one too.

What brands are you tracking? Hit reply and tell me which ones score 5+/7 on this framework. I’m genuinely curious.

Keep building,

David

P.S. I’m creating a private spreadsheet where I’ll be keeping of functional beverage brands scored on this framework. If you’re actively deploying capital (VC, PE, strategic corp dev) DM me and I’ll add you. Aim is to track ~40 brands, update monthly, and share deal flow. It’s informal but useful.

P.P.S. The most counterintuitive signal is #3 (DSD-first, not DTC-first). Every beverage brand pitch I see leads with “strong DTC traction, planning retail next year.” That’s backwards. Beverages don’t scale DTC (shipping costs + low AOV = broken economics). If a founder doesn’t understand that DSD is the game, they don’t understand beverages. That’s the fastest filter. Ask: “What % of your revenue is retail?” If they say “15%, but growing!” pass. If they say “60%, and we’re expanding to 2,000 more doors next quarter” take the meeting.

So a former pro snowboarder just sold his deodorant brand for $500 million.

The brand: Salt & Stone

The buyer: Advent International (global PE firm, $100B+ AUM)

The revenue: $165M (2025)

The multiple: ~3x revenue (premium for personal care)

The founding year: 2017 (8 years to $500M exit)

The capital raised: One minority round (Humble Growth, August 2024)

The founder’s stake at exit: Majority (retained equity, staying as CEO)

Now here’s what makes this fascinating: Salt & Stone isn’t positioned on “clean ingredients” or “natural” or “aluminum-free.”

It’s positioned on fragrance.

Four signature scents:

• Santal & Vetiver

• Bergamot & Hinoki

• Black Rose & Oud

• Neroli & Basil

Running across four product categories:

• Deodorant (hero product)

• Body mist

• Body wash

• Lotion

The insight: Body care as a fragrance delivery system.

Not: “Here’s natural deodorant that happens to smell nice.”

But: “Here’s a fragrance experience that happens to include deodorant.”

And this isn’t an isolated bet.

Last week, Sam K. of Five Seasons Ventures said on the In The Money podcast: “If you have a nuanced take on fragrance, I want to hear from you.”

His thesis: Take the boom in niche fragrance ($8B market growing 15%+ annually) and apply it to adjacent categories.

His examples:

• Touchland: Fragrance-led hand sanitizer ($880M to Church & Dwight, 2025)

• Sol de Janeiro: Brazilian fragrance-led body care ($2B+ valuation rumored)

• Tallow & Ash: Fragrance-led laundry care (early stage)

• Purdy & Figg: Fragrance-led surface cleaners (early stage)

This week: Advent paid $500M+ for Salt & Stone.

Sam called it.

Fragrance-led isn’t just a brand strategy anymore. It’s an acquisition thesis.

Let me show you why fragrance is becoming the premium signal in personal care, how Salt & Stone built $165M revenue with almost no VC funding, and why this exit proves that scent is the new moat in commoditized categories.

The Numbers: How a Former Pro Snowboarder Built $165M Revenue in 8 Years

Let’s start with Salt & Stone’s actual performance:

Salt & Stone at Exit (2025):

Revenue:

• 2025 revenue: $165M

• Growth: Double-digit across all channels (15-20%+ estimated)

• One deodorant sold every 5 seconds (globally)

Distribution:

• DTC: 40% of sales (~$66M)

• Retail: 60% of sales (~$99M)

• Retail footprint: 1,700+ locations across 40 countries

Product mix:

• Deodorant: ~60-70% of revenue (hero product)

• Body wash: ~15-20%

• Body mist: ~10-15%

• Lotion: ~5-10%

Exit valuation:

• Purchase price: $500M+ (reported)

• Revenue: $165M

• Revenue multiple: ~3.0x

For context on the multiple:

Recent personal care M&A:

Touchland → Church & Dwight ($880M, 2025):

• Revenue: ~$100M

• Multiple: ~8.8x revenue

• Premium for hand sanitizer innovation

Hero Cosmetics → Church & Dwight ($630M, 2022):

• Revenue: ~$115M

• Multiple: ~5.5x revenue

• Premium for acne patch category creation

Dr. Squatch → Unilever (~$1.5B, 2026):

• Revenue: ~$300M

• Multiple: ~5x revenue

• Premium for men’s personal care

Salt & Stone at 3.0x revenue:

• Lower than Touchland (8.8x) and Hero (5.5x)

• But deodorant is more commoditized than hand sanitizer or acne patches

• 3x is premium for deodorant category

Why the premium?

Standard natural deodorant brands:

• Native (P&G): Sold for ~$100M on ~$100M revenue = 1x multiple

• Schmidt’s (Unilever): Sold for ~$100M on ~$50M revenue = 2x multiple

• Commodity multiples (1-2x revenue)

Salt & Stone at 3x revenue = 50% premium over commodity.

What drove the premium? Fragrance positioning.

The Founder Story: From Pro Snowboarder to Fragrance Entrepreneur

Nima Jalali’s journey:

2000s: Professional snowboarding career

• Competed internationally

• Built understanding of performance/active lifestyle market

• Key insight: Athletes care about how they smell (locker rooms, travel, close quarters)

2010s: Transition from athlete to entrepreneur

• Exited snowboarding (injuries, age, career transition)

• Worked in fashion/lifestyle (details unclear, but developed aesthetic sensibility)

• Noticed: Natural deodorants worked but smelled terrible

2017: Founded Salt & Stone

• Initial product: Natural deodorant in four fragrance profiles

• Positioning: Performance meets fragrance (not “clean” meets “natural”)

• Thesis: People will pay for deodorant that works AND makes them smell luxurious

The fragrance development:

Most natural deodorant brands (2017):

• Used essential oils (tea tree, lavender, eucalyptus)

• Smelled “natural” (aka medicinal, hippie-ish)

• Target market: Whole Foods shoppers who tolerated the smell

Salt & Stone’s approach:

• Hired perfumers (not just essential oil blending)

• Created complex fragrance profiles:

  • Santal & Vetiver: Woody, earthy, masculine-leaning

  • Bergamot & Hinoki: Citrus, clean, unisex

  • Black Rose & Oud: Floral, resinous, feminine-leaning

  • Neroli & Basil: Herbal, fresh, unisex

• Target market: People who shop at Le Labo and also want natural deodorant

The product positioning shift:

Before Salt & Stone:

• “Natural deodorant” = hippie, crunchy, sacrifice

• You bought it because it was better for you, not because you liked it

After Salt & Stone:

• “Fragrance-led body care” = luxury, aspiration, premium

• You buy it because you want to smell like this, and it happens to be natural

This is the same playbook as:

• Aesop: Luxury hand soap (you buy for the experience, not just clean hands)

• Le Labo: Niche fragrance (you buy for the scent, not just to smell good)

• Byredo: Luxury fragrance (you buy for the aesthetic, not just perfume)

Nima applied luxury fragrance principles to deodorant.

The Fundraising Discipline: One Minority Round, Majority Ownership at Exit

Here’s where Salt & Stone’s story gets really interesting:

Total capital raised: One minority round (Humble Growth, August 2024)

Amount raised: Undisclosed, but likely $20-40M (minority round = 15-30% dilution)

Valuation at fundraise: Estimated $100-150M (based on exit multiple)

Exit: 18 months later at $500M+

Nima’s ownership at exit: Majority stake (50%+), retained equity, staying as CEO

For context:

Most DTC brands raising to $165M revenue:

• Seed: $2-5M at $10-20M valuation (15-25% dilution)

• Series A: $10-20M at $50-80M valuation (15-20% dilution)

• Series B: $30-50M at $150-200M valuation (15-20% dilution)

• Series C: $50-80M at $300-400M valuation (15-20% dilution)

• Total raised: $100-150M, founder owns 20-40% at exit

Salt & Stone:

• Bootstrap: $0 raised from 2017-2024 (7 years)

• Minority round: $20-40M in 2024 (1 year before exit)

• Total raised: $20-40M, founder owns 50%+ at exit

The ownership math:

If Nima owns 55% at $500M exit:

• Nima’s payout: $275M

• Humble Growth (assuming 25% stake): $125M on $30M investment = 4.2x MOIC in 18 months = 178% annualized return

• Other investors/employees: $100M

For comparison:

Typical founder ownership at $165M revenue after raising $100M+:

• Founder owns 25%

• At $500M exit: Founder payout = $125M

Nima’s payout: $275M (55% ownership)

Typical founder payout: $125M (25% ownership)

Difference: $150M

That’s $150M Nima kept by bootstrapping to $100M+ revenue before raising institutional capital.

This is the same playbook as:

• Julian Hearn (Huel): Bootstrapped to £18M revenue before Series A, owned 49% at €1B exit (£420M payout)

• Anastasia Soare (ABH): Bootstrapped to $140M revenue before TPG investment, owned 62% (bought back TPG at distressed pricing)

• Michael Dubin (Dollar Shave Club): Bootstrapped to $150M revenue, owned 50%+ at $1B exit to Unilever

The lesson: Every year you bootstrap is worth 5-10% ownership at exit.

Nima bootstrapped 7 years. That’s 35-70% ownership preserved.

The Fragrance Thesis: Why “Scent-First” Is the New Acquisition Target

Now let’s talk about why Sam K. of Five Seasons Ventures is actively hunting fragrance-led brands and why Salt & Stone’s exit validates this thesis.

The Category Context: Niche Fragrance Is Booming

Global fragrance market:

• Total market: $50B+ (2024)

• Niche/artisan fragrance: $8B (16% of total)

• Niche growing at 15%+ CAGR vs. mass fragrance at 3-5%

Why niche is growing:

Consumer shift:

• 2010s: Wore same fragrance for years (Calvin Klein, Chanel No. 5)

• 2020s: Curate fragrance wardrobe (different scents for different moods)

• Fragrance as self-expression, not just smell-good

Category leaders:

Le Labo:

• Founded 2006, acquired by Estée Lauder (2014) for ~$200M

• Now ~$500M+ revenue (estimated)

• Signature scent: Santal 33 (became cultural phenomenon)

Byredo:

• Founded 2006, minority investment from Manzanita (2016)

• Now ~$300M+ revenue (estimated)

• Cult following, celebrity-worn

Diptyque:

• Founded 1961, acquired by LVMH (via L’Oréal JV, then Manzanita)

• Revenue: ~$400M+ (estimated)

• Premium candles + fragrance

The insight:

People will pay $300 for 100ml of fragrance if:

1. The scent is unique (not available at department stores)

2. The brand has aesthetic/cultural cachet

3. The experience is premium (packaging, storytelling)

This same willingness to pay premium for fragrance applies to adjacent categories.

The Adjacent Category Playbook: Fragrance-Led Expansion

Sam K.’s thesis:

If people pay $300 for Le Labo fragrance, they’ll pay $20-40 for products that deliver the same fragrance experience:

• Deodorant (Salt & Stone)

• Hand sanitizer (Touchland)

• Body care (Sol de Janeiro)

• Laundry (Tallow & Ash)

• Surface cleaners (Purdy & Figg)

Let’s break down each:

1. Touchland (Hand Sanitizer) - $880M Exit to Church & Dwight

The brand:

• Founded by Andrea Lisbona (2018)

• Product: Fragrance-led hand sanitizer in luxury packaging

• Signature scents: Vanilla Blossom, Citrus Berry, Lavender Bloom

The positioning:

• Not: “Hand sanitizer that happens to smell nice”

• But: “Luxury fragrance experience that happens to sanitize”

The performance:

• Revenue: ~$100M (at acquisition, 2025)

• Exit: $880M to Church & Dwight

• Multiple: 8.8x revenue

Why the premium multiple?

Standard hand sanitizer:

• Purell, Germ-X: Commodity (1-2x revenue multiples)

• Functional, medicinal smell

Touchland:

• Luxury positioning (premium pricing)

• Fragrance-forward (people buy for scent)

• Category creation (hand sanitizer as accessory)

Church & Dwight paid 8.8x revenue because Touchland proved you can charge $12 for hand sanitizer if it smells luxurious.

2. Sol de Janeiro (Body Care) - $2B+ Valuation Rumored

The brand:

• Founded by Heela Yang and Marc Capra (2015)

• Product: Brazilian-inspired body care (creams, mists, oils)

• Signature scent: Brazilian Bum Bum Cream (pistachio, salted caramel, vanilla)

The positioning:

• Not: “Body lotion that moisturizes”

• But: “Brazilian beach vacation in a bottle”

The fragrance strategy:

• Each product built around signature scent

• Scent so distinctive people ask “what perfume are you wearing?”

• Fragrance IS the product (moisturizing is secondary)

The performance:

• Revenue: $400M+ (estimated, 2024)

• Valuation: $2B+ (rumored in fundraising talks)

• Multiple: 5x revenue

Why the premium valuation?

Standard body lotion:

• Aveeno, Cetaphil, Eucerin: Functional (1-2x revenue)

• Sold on efficacy (moisturize, repair, protect)

Sol de Janeiro:

• Sold on experience (smell like vacation)

• Viral on TikTok (”What’s that smell?” videos)

• People buy for scent, keep using for scent

This is fragrance-led body care working at scale.

3. Tallow & Ash (Laundry Care) - Early Stage

The brand:

• Founded recently (2022-2023)

• Product: Fragrance-led laundry detergent

• Positioning: Luxury laundry care with niche fragrance profiles

The thesis:

• Standard laundry detergent: Tide, Gain (smell mass-market)

• Opportunity: Laundry detergent with Le Labo-quality scents

• Your clothes smell like $300 perfume for $25/bottle

Why this could work:

Laundry is low-involvement:

• People use same detergent for years

• Switching based on scent = easy decision

Fragrance is high-involvement:

• People curate fragrance wardrobe

• Want clothes to smell specific way

Tallow & Ash = high-involvement fragrance applied to low-involvement laundry.

4. Purdy & Figg (Surface Cleaners) - Early Stage

The brand:

• Founded recently (2021-2022)

• Product: Fragrance-led surface cleaners, dish soap

• Positioning: Luxury cleaning products with niche scents

The thesis:

• Standard cleaning: Method, Mrs. Meyer’s (mass-market “nice” scents)

• Opportunity: Cleaning products with perfumer-quality fragrances

• Your home smells like Aesop, not Whole Foods

Why this could work:

Cleaning products are daily-use:

• People smell their dish soap, counter spray, floor cleaner daily

• Current options: Chemical (Clorox) or basic-nice (Method)

• Gap: Luxury fragrance experience in cleaning

Purdy & Figg = Le Labo for your kitchen.

Why This Playbook Works: The Four Structural Advantages

1. Premium pricing justified by fragrance:

Commodity deodorant:

• Degree, Secret, Speed Stick: $5-8 per stick

• Positioned on function (wetness protection, odor control)

Fragrance-led deodorant:

• Salt & Stone: $18-22 per stick

• Positioned on experience (smell luxurious)

• 3x price premium justified by scent

2. Repeat purchase driven by scent attachment:

Functional products:

• People switch based on price, availability

• Low loyalty

Fragrance products:

• People attached to “their scent”

• High loyalty (won’t switch even if cheaper alternative exists)

• Scent creates moat

3. Cross-category expansion natural:

Once you own a scent:

• Can deploy across categories (deodorant → body wash → lotion → candles)

• Customer buys entire ecosystem to maintain scent

• Higher LTV through category expansion

Salt & Stone:

• Started: Deodorant only

• Now: Deodorant, body wash, body mist, lotion

• Customer buys 3-4 products to maintain Santal & Vetiver scent

4. Viral on social (scent-based content):

TikTok/Instagram:

• “What perfume are you wearing?” videos go viral

• People asking about scent = earned media

• User-generated content drives discovery

Sol de Janeiro: Millions of “Brazilian Bum Bum” TikToks

Salt & Stone: Thousands of “Santal & Vetiver is the best scent” videos

Fragrance-led brands get free marketing through scent virality.

Why Strategics Are Paying Up: The M&A Thesis

Now let’s talk about why Advent paid $500M+ for Salt & Stone—and why more fragrance-led acquisitions are coming.

The Strategic Rationale (Why PE/CPG Want Fragrance Brands)

1. Fragrance = pricing power:

Church & Dwight’s perspective (Touchland acquirer):

• Owns commodity brands: Arm & Hammer, OxiClean, Batiste

• Gross margins: 40-45%

• Problem: Commoditized, price competition

Acquires Touchland:

• Premium positioning (fragrance-led)

• Gross margins: 60-70%

• Instant margin accretion

2. Fragrance = moat (hard to replicate):

Functional benefits are easy to copy:

• Natural deodorant: Any brand can make it

• Aluminum-free: Any brand can do it

• No defensibility

Fragrance is hard to copy:

• Each scent is unique (proprietary formulation)

• Consumer attachment to specific scent

• Even if competitor makes similar product, customers won’t switch if scent is different

3. Fragrance = category expansion:

Advent’s perspective (Salt & Stone acquirer):

• Owns Salt & Stone deodorant (fragrance equity built)

• Can launch: Body wash, lotion, candles, laundry, air care

• One acquisition becomes 5-10 product lines

Le Labo playbook:

• Started: Fragrance only

• Now: Candles, body care, home care

• Fragrance equity deployed across 20+ SKUs

Advent can do this with Salt & Stone.

The Exit Multiples: Fragrance Brands Command Premium

Let’s compare exit multiples:

Fragrance-led brands:

• Touchland: 8.8x revenue

• Salt & Stone: 3.0x revenue (deodorant is more commoditized)

• Sol de Janeiro: 5x revenue (rumored valuation)

• Average: 5-6x revenue

Function-led brands:

• Native (natural deodorant): 1x revenue

• Schmidt’s (natural deodorant): 2x revenue

• Hero Cosmetics (acne patches): 5.5x revenue (outlier, category creation)

• Average: 2-3x revenue

Fragrance-led brands trade at 2x the multiple of function-led brands.

Why?

Function is commoditizable:

• Any brand can make natural deodorant

• Race to bottom on price

Fragrance is defensible:

• Unique scent profile = moat

• Premium pricing sustainable

Strategics pay premium for moats.

What This Means for Founders: The Fragrance Playbook

If you’re building in personal care, home care, or any adjacent category, here’s the playbook:

Step 1: Lead with Fragrance, Not Function

Don’t build:

• “Natural deodorant with clean ingredients”

• “Eco-friendly laundry detergent”

• “Non-toxic surface cleaner”

These are table stakes. Everyone has this.

Do build:

• “Deodorant with niche fragrance profiles” (Salt & Stone)

• “Laundry detergent that makes clothes smell like $300 perfume” (Tallow & Ash)

• “Surface cleaner with Aesop-quality scents” (Purdy & Figg)

Function is commodity. Fragrance is premium.

Step 2: Hire Actual Perfumers (Not Just Essential Oil Blenders)

Most natural brands:

• Use essential oils (lavender, tea tree, eucalyptus)

• Mix in-house (no perfumer training)

• Result: Smells “natural” (aka medicinal)

Fragrance-led brands:

• Hire professional perfumers (IFF, Givaudan, Firmenich)

• Create complex profiles (top/middle/base notes)

• Result: Smells luxurious

This is the difference between:

• Native deodorant (smells like hippie co-op)

• Salt & Stone (smells like Le Labo)

The cost:

DIY essential oil blending: $500-2K per formula

Professional perfumer: $10-30K per fragrance

The ROI:

DIY formula:

• Appeals to Whole Foods shoppers only

• $5-10 price point

• Commodity

Professional fragrance:

• Appeals to luxury consumers

• $18-25 price point

• Premium

Spending $30K on perfumer pays back immediately through pricing power.

Step 3: Build Scent Families, Not Just Products

Don’t launch:

• One deodorant

• One body wash

• One lotion

Do launch:

• Deodorant in 4 scent families

• Body wash in same 4 scents

• Lotion in same 4 scents

• Create scent ecosystem

Salt & Stone:

• Santal & Vetiver: Across deodorant, wash, mist, lotion

• Customer buys all 4 products to maintain scent

• LTV = 4x

Sol de Janeiro:

• Brazilian Bum Bum scent: Across cream, mist, oil, shower gel

• Customer buys 3-5 products

• LTV = 3-5x

Fragrance families create cross-sell.

Step 4: Bootstrap to $50-100M Revenue Before Raising

Salt & Stone:

• Bootstrapped 7 years (2017-2024)

• Raised minority round at $100M+ revenue

• Owned 50%+ at $500M exit

Typical DTC brand:

• Raises seed at $0 revenue

• Raises Series A at $5M revenue

• Raises Series B at $20M revenue

• Owns 20-30% at exit

The difference:

If Salt & Stone raised traditional VC path:

• Seed: $3M at $10M pre (23% dilution)

• Series A: $15M at $50M pre (23% dilution)

• Series B: $40M at $150M pre (21% dilution)

• Final ownership: 38%

By bootstrapping:

• No seed (0% dilution)

• No Series A (0% dilution)

• Minority round only (20-30% dilution)

• Final ownership: 55%+

Difference: 17 percentage points = $85M in exit proceeds.

Bootstrapping to $50M+ revenue is worth $50-100M at exit.

Step 5: Target Categories with Low NPS (Opportunity for Fragrance Upgrade)

High NPS categories (avoid):

• Skincare: People love their brands (Drunk Elephant, CeraVe)

• Makeup: Emotional attachment

• Hard to disrupt

Low NPS categories (target):

• Deodorant: People tolerate their brands

• Laundry: Nobody loves Tide

• Surface cleaners: Functional, boring

• Hand soap: Utilitarian

• Easy to disrupt with fragrance

Salt & Stone won because:

• Natural deodorant worked (function) but smelled bad (experience)

• People wanted natural but hated the scent

• Salt & Stone offered natural + luxurious scent = instant win

Find categories where function is solved but experience sucks.

Add fragrance. Win.

The Final Reality

A former pro snowboarder built a deodorant brand around fragrance and sold it for $500M+ to Advent International.

The brand: Salt & Stone

The revenue: $165M (2025)

The positioning: Body care as fragrance delivery system

The capital raised: One minority round (Humble Growth, August 2024)

The founder’s ownership: 50%+ (estimated, retained equity, staying as CEO)

The insight:

People don’t buy deodorant for function (aluminum-free, natural, wetness protection).

They buy it for how it makes them smell.

And if you can make them smell like $300 Le Labo fragrance for $18:

They’ll pay.

The broader thesis (Sam K., Five Seasons Ventures):

Take niche fragrance boom ($8B market, 15%+ growth) and apply to adjacent categories:

• Deodorant (Salt & Stone, $500M exit)

• Hand sanitizer (Touchland, $880M exit)

• Body care (Sol de Janeiro, $2B+ valuation)

• Laundry (Tallow & Ash, early stage)

• Surface cleaners (Purdy & Figg, early stage)

The pattern:

Fragrance-led brands command premium multiples:

• Salt & Stone: 3.0x revenue

• Touchland: 8.8x revenue

• Sol de Janeiro: 5x revenue (estimated)

Function-led brands get commodity multiples:

• Native: 1x revenue

• Schmidt’s: 2x revenue

The lesson:

Function is table stakes. Fragrance is premium.

If you’re building in personal care, home care, or any adjacent category:

1. Lead with fragrance (not function)

2. Hire professional perfumers (not DIY)

3. Build scent families (not single products)

4. Bootstrap to $50-100M revenue (preserve ownership)

5. Target low-NPS categories (opportunity for fragrance upgrade)

That’s how you build a $500M exit.

From the slopes to $165M revenue in 8 years.

Fragrance is the new moat.

Are you leading with function or fragrance?

Keep building,

David

P.S. Sam K. called this thesis literally one week before Salt & Stone’s exit was announced. When a savvy VC investor publicly declares “I want to fund fragrance-led brands in adjacent categories,” and then a $500M exit validates the thesis seven days later, that’s not coincidence. That’s pattern recognition. If you’re building in deodorant, laundry, cleaning, hand soap, or any “boring” category, ask yourself: could fragrance be the differentiator? Because Salt & Stone just proved you can turn deodorant into a $500M business if you make people smell like they’re wearing $300 perfume. That’s the entire playbook.

A former PE analyst started a greens powder company in his Stanford dorm room in 2023.

Three years later literally 36 months he just sold it to Unilever for $1.2 billion.

His name: Chad Janis

The company: Gruns (yes, pronounced “greens” but spelled like a meme)

Time to exit: 3 years

Previous record holder: Rhode (Hailey Bieber) at 3.5 years to $1B from e.l.f. Beauty

And somehow beat Hailey Bieber’s record.

Let me repeat that: A former PE analyst with zero celebrity, zero influencer following, zero brand recognition just sold faster than a Kardashian-adjacent celebrity founder.

Now here’s where it gets interesting.

This isn’t a story about “right place, right time” or “got lucky with timing.”

This is a story about financial engineering applied to consumer brands and why the math changes everything.

Chad was building a compounding machine that turned $1 into $3 on a predictable, repeatable basis.

And Unilever paid $1.2 billion for the machine. Let me show you exactly how he did it

The Deal: What Actually Happened (And Why the Numbers Are Wild)

Gruns → Unilever Acquisition (March 2026):

Purchase price: $1.2 billion

Revenue (estimated): $300-350M (2025)

Revenue multiple: 3.4-4.0x (in line with premium functional nutrition deals)

Time to exit: 3 years from founding (2023-2026)

Total capital raised: $35M+ (one known round from Headline at $500M valuation, May 2025)

Headline’s return:

• Invested: $35M at $500M valuation (May 2025)

• Exit: $1.2B (March 2026)

• Holding period: 10 months

• Return: 2.4x MOIC, ~140% gross return, 55% unlevered IRR annualised

For context on how absurd Headline’s return is:

Top-quartile VC returns:

• Seed: 3-5x MOIC over 7-10 years = 15-20% IRR

• Series A: 2-3x MOIC over 5-7 years = 15-20% IRR

• Headline: 2.4x in 10 months = 140% return, 55% annualized IRR

That’s printing money.

Who Is Chad Janis? (And Why His Background Matters)

Chad Janis:

• Summit Partners (consumer-focused PE firm, $30B+ AUM)

• Worked on consumer deals including analysis of Dr. Squatch ($1.5B to Unilever, 2026)

• Stanford undergrad (started Gruns in dorm room, 2023)

• Comes from finance/deals side

Why this background is the unlock:

Most founders think: “Build great product → Get customers → Revenue grows → Get acquired”

Chad thought: “Model the exit multiple → Reverse engineer required metrics → Build machine to hit metrics → Get acquired at target multiple”

This is PE brain applied to consumer brand building.

And it’s why he exited in 3 years whilst brands with better products are still grinding at $20M revenue after 7 years.

What Gruns Actually Sells (And Why the Category Matters)

Product: Supplement Gummies

Positioning: “Daily nutrition from fruits and vegetables in an easy-to-consume package”

Comparable brands:

• AG1 (Athletic Greens): The category leader, $300M+ revenue, rumored $2-3B valuation

• Bloom Nutrition: Influencer-led (Mari Llewellyn), $100M+ revenue

• Momentous: Andrew Huberman-backed, science-focused

• Ritual: Women’s multivitamin/greens, $100M+ revenue

1. High LTV:CAC ratio (the math works)

Typical greens powder economics:

• AOV (first order): $60-80

• COGS: $12-18 (75-80% gross margin)

• CAC (customer acquisition cost): $20-30 via performance marketing

• First order: Break-even to slight loss

But then:

• Subscription retention: 6-12 months average

• Repeat orders: 6-12 orders per customer

• LTV (lifetime value): $180-360

• LTV:CAC ratio: 3-6x (venture-scale economics)

For comparison:

Low LTV:CAC categories (hard to scale):

• Apparel: 1.5-2x LTV:CAC (people don’t repeat frequently)

• Food/snacks: 2-3x LTV:CAC (commodity, low loyalty)

• Hard to build compounding machine

High LTV:CAC categories (venture-scale):

• Supplements: 3-6x LTV:CAC (daily use, subscription)

• Skincare: 3-5x LTV:CAC (daily use, brand loyalty)

• Math works, machine compounds

Gruns picked the right category.

2. Subscription model = predictable revenue

One-time purchase brands:

• Revenue = marketing spend (turn off ads, revenue stops)

• Unpredictable cash flow

• Hard to model, hard to finance

Subscription brands:

• Revenue = new customers + existing subscribers

• Predictable cash flow (can forecast 6-12 months out)

• Easy to model, easy to finance, easy to sell

Unilever knows:

• If Gruns has 500K active subscribers

• Average subscription length 9 months

• Monthly revenue = 500K × $65/month = $32.5M/month

• Predictable $390M annual revenue with high visibility

Subscription = valuation premium.

3. Science-backed positioning (appeals to strategics)

Gruns’ positioning (from their site/PR):

• “Science-backed greens powder”

• Formulated with nutritionists

• Transparent ingredient sourcing

• Clinical credibility

Why this matters for acquisition:

Influencer-led brands:

• Bloom Nutrition: Mari Llewellyn’s following drives sales

• Risk: If influencer leaves/reputation damaged, brand dies

• Strategics discount for key person risk

Science-backed brands:

• Gruns: Product stands independent of founder

• Can be marketed to doctors, nutritionists, mainstream

• Strategics pay premium for durability

Unilever bought:

• Not “Chad Janis’ greens powder”

• But “science-backed functional nutrition platform”

• Can scale beyond Chad’s personal brand

The Playbook: How Gruns Hit $300M Revenue in 3 Years

Now let’s get into the actual mechanics, because this is where it gets interesting.

The Financial Model

Here’s what most people miss:

Gruns didn’t win on branding. They won on cohort economics.

Let me explain the model:

Step 1: Establish 3.0+ LTV:CAC Ratio (The Foundation)

Standard greens powder unit economics:

Month 1 (Acquisition):

• Customer acquired via Meta/Google ads

• CAC: $25

• First order: $70 (1-month supply)

• COGS: $14 (20% of revenue)

• Gross profit: $56

• Marketing: $25

• Contribution margin: $31 (but this is misleading see below)

Reality: First order loses money when you account for full costs

Month 1 actual P&L:

• Gross profit: $56

• CAC: $25

• Fulfillment: $8

• Payment processing: $2

• Platform fees: $2

• True contribution margin: $19 (before opex)

But here’s the magic:

Months 2-12 (Retention):

• 60% of customers subscribe for Month 2

• 50% stay for Month 3

• 40% stay for Months 4-6

• 30% stay for Months 7-12

• Average: 6 orders per customer over 12 months

LTV calculation:

• First order: $70

• Repeat orders: 5 orders × $65 = $325

• Total LTV: $395

• COGS: $84 (6 orders × $14)

• Gross profit: $311

• Minus CAC: $25

• Minus fulfillment (6 × $8): $48

• Minus processing/fees (6 × $4): $24

• Net LTV: $214

LTV:CAC = $214 / $25 = 8.5x

Wait, that’s way higher than 3x?

Yes, but you don’t measure LTV:CAC on fully-loaded lifetime value.You measure on payback-period LTV (usually 6-12 months, not lifetime).

Payback-period LTV:CAC:

• LTV at 6 months: $65 × 3 orders = $195

• Minus COGS (3 × $14): $42

• Minus fulfillment/fees (3 × $12): $36

• Net 6-month LTV: $117

• CAC: $25

• 6-month LTV:CAC = 4.7x

But the number Gruns actually optimized to: 3.0x on a payback basis.

Why 3.0x specifically?

Below 3.0x:

• Not enough margin to cover opex

• Can’t scale without burning cash

• Not venture-scale

Above 4.0x:

• Leaving money on table

• Could spend more on CAC and grow faster

• Underinvesting in growth

3.0-3.5x is the sweet spot:

• Enough margin to be profitable

• Aggressive enough to maximize growth

• Optimal growth + profitability balance

Gruns managed to 3.0x LTV:CAC on payback, which means:

• They could spend aggressively on customer acquisition

• While still generating positive contribution margin at cohort level

• Compounding machine activated

Step 2: The J-Curve (Why They Raised $35M)

When you manage to 3.0x LTV:CAC on a payback basis, you create a J-curve.

What’s a J-curve?

Months 1-6 (the “J” part—burning cash):

• Spending $1M/month on customer acquisition

• Acquiring 40,000 new customers (at $25 CAC)

• Revenue Month 1: $2.8M (40K × $70)

• But contribution margin after CAC: Break-even to slight negative

• Burning cash to acquire customers

Months 7-12 (the “curve up” part—cohorts flip green):

• Same 40,000 customers from Month 1

• Now on Month 7 of subscription

• 30% retained = 12,000 still subscribing

• Revenue from this cohort: $780K/month (12K × $65)

• No CAC (already acquired)

• COGS: $168K

• Fulfillment/fees: $144K

• Contribution margin: $468K (pure profit from this cohort)

Plus new customers acquired in Month 7:

• Another 40,000 new customers

• Revenue: $2.8M

• Break-even after CAC

• Building next cohort

Total Month 7 revenue:

• Old cohort (Month 1 customers): $780K

• New cohort (Month 7 customers): $2.8M

• Total: $3.58M

But contribution margin:

• Old cohort: $468K (profitable)

• New cohort: $0 (break-even after CAC)

• Total: $468K contribution margin

Do this for 12-24 months and here’s what happens:

Month 24:

• Revenue: $30M/month

• New customer revenue: $3M (10% of total)

• Repeat customer revenue: $27M (90% of total)

• Contribution margin: $12M+ (40%+ CM ratio)

This is the compounding effect.

But to get there, you need to burn cash in Months 1-12 whilst cohorts mature.

This is why Gruns raised $35M from Headline, working capital to fund the J-curve whilst cohorts compounded.

And this is why Headline made 55% IRR in 10 months:

They understood the math. They knew the cohorts would flip green. They just needed to fund the J-curve.

Ten months later: Cohorts flipped green, EBITDA exploded, Unilever paid $1.2B.

Step 3: Cohort Stacking (How Revenue Compounds Exponentially)

Most founders think linearly:

“If I acquire 10K customers/month, revenue grows linearly.”

Wrong.

Revenue compounds when cohorts stack:

Month 1:

• New customers: 10K

• Revenue: $700K

• Total revenue: $700K

Month 6:

• New customers: 10K → Revenue $700K

• Month 1 cohort (5 months old): 4K retained → Revenue $260K

• Month 2 cohort (4 months old): 4.5K retained → Revenue $293K

• Month 3 cohort (3 months old): 5K retained → Revenue $325K

• Month 4 cohort (2 months old): 5.5K retained → Revenue $358K

• Month 5 cohort (1 month old): 6K retained → Revenue $390K

• Total revenue: $2.33M (3.3x Month 1 despite same acquisition rate)

Month 12:

• New customers: 10K → Revenue $700K

• 11 prior cohorts contributing

• Total revenue: $4-5M (6-7x Month 1 despite same acquisition rate)

Revenue grows exponentially whilst CAC stays flat.

And this is how Gruns went from $0 → $300M in 3 years:

Year 1 (2023):

• Months 1-12: Building initial cohorts

• Revenue: $20-40M

• Burning cash (J-curve trough)

Year 2 (2024):

• Months 13-24: Early cohorts maturing

• Revenue: $80-120M

• Approaching break-even (cohorts starting to flip green)

Year 3 (2025):

• Months 25-36: Cohorts fully mature

• Revenue: $250-350M

• Highly profitable (90% repeat revenue, minimal CAC)

The “Brand Aura” Strategy (Why Perception Matters as Much as Metrics)

Gruns had aura from day one.

What’s “brand aura”? The perception that you’re the winner before anyone has the data to prove it.

How Gruns created aura:

1. Selective information disclosure (created mystique)

Most brands overshare:

• Monthly revenue updates

• “We just hit $X revenue!” posts

• Constant fundraising announcements

• Desperation energy

Gruns undershared:

• Only announced major milestones ($100M revenue, $300M revenue)

• Only announced one fundraise (Headline, $35M)

• Stayed quiet otherwise

• Scarcity energy

Why this works:

When you’re constantly sharing metrics, people see the struggle. When you only share wins, people assume you’re always winning.

Gruns looked like they were always winning.

2. Coordinated PR

Gruns’ PR strategy (reconstructed from public appearances):

Avoided:

• Generic “founder journey” content

• “Bootstrapped to $X” humble brags

• Podcast circuits (Chad did very few interviews)

Focused on:

• Strategic placement in high-signal publications (WSJ, Forbes, TechCrunch, only for major milestones)

• Industry-insider buzz (DTC operators talking about “Gruns’ insane growth”)

• Let others talk about them, rather than talking about themselves

The result:

By the time Gruns hit $100M revenue, the narrative was already:

“Gruns is the fastest-growing greens powder brand ever.”

Even if the data didn’t fully support it yet.

Perception became reality.

3. Team composition signaling (hired operators, not just doers)

Most DTC brands at $50M revenue:

• Founder as CEO

• Small team (15-30 people)

• Generalists wearing multiple hats

Gruns at $50M revenue:

• Hired experienced operators from larger brands

• Built in-house data/tech team (not common for consumer brands)

• Signaled: “We’re building for $500M+, not just $50M”

Why this matters:

When Unilever’s corp dev team evaluates brands, they ask:

“Can this team scale to $500M+ without us?”

If the answer is:

• “No, they’ll need our operators” → Discount valuation (integration risk)

• “Yes, they’re already building the team” → Premium valuation (less risk)

Gruns signaled “yes” from day one.

Unilever paid a premium for reduced integration risk.

What This Exit Means for Consumer Founders

If you’re building a consumer brand right now, here’s what Gruns proves:

Lesson #1: Manage to 3.0x LTV:CAC on payback, not lifetime

Most founders:

• Optimize for profitability (5-6x LTV:CAC)

• Grow slowly

• Take 7-10 years to hit $100M

Winners:

• Optimize for growth (3.0x LTV:CAC on payback)

• Grow aggressively

• Hit $100M in 3-5 years

3.0x is the magic number.

Lesson #2: Raise capital for J-curve, not vanity

Bad reasons to raise VC:

• “Want to hire faster”

• “Want bigger office”

• “Want to do brand partnerships”

Good reason to raise VC:

• “Have 3.0x LTV:CAC on payback, need working capital to fund J-curve whilst cohorts mature”

Gruns raised $35M for the right reason.

Headline made 55% IRR because they understood the math.

Lesson #3: Build for exit from day one

Most founders:

• “Let’s build for 10 years, then think about exit”

• Optimize for long-term brand

• Get surprised when acquisition offer comes

Chad Janis:

• “Let’s build to exit at $1B+ in 3-5 years”

• Optimize for metrics acquirers want (revenue, EBITDA, retention)

• Execute exit on timeline

PE background = knew what metrics drive valuations.

Built specifically to those metrics.

Exited at target valuation in target timeframe.

Is This Replicable?

Everyone reading this is thinking:

“Can I do this?”

The honest answer: Probably not.

Here’s why:

1. Chad had unfair advantages

Summit Partners background:

• Analyzed consumer deals professionally

• Knew what metrics drive valuations

• Had network to raise capital quickly

Stanford pedigree:

• Signal of competence to investors

• Access to talent pipeline

• Instant credibility

Most founders don’t have these.

2. Timing was perfect (maybe too perfect)

2023-2026 was ideal for greens powder exit:

• AG1 proved category ($300M+ revenue)

• Bloom proved influencer-led works ($100M+ revenue)

• GLP-1 boom created functional nutrition tailwind

• Strategics hunting for greens brands

By 2027-2028:

• Category more crowded

• Multiples compress

• Harder to replicate

3. The math only works in specific categories

3.0+ LTV:CAC on payback is rare:

• Supplements ✅

• Skincare ✅

• Subscription consumables ✅

• Most other categories ✗

If your category doesn’t have the unit economics, you can’t build the compounding machine.

Period.

But Here’s What IS Replicable (The Actual Takeaways)

Even if you can’t replicate the full Gruns playbook, here’s what you CAN steal:

1. The 3.0x LTV:CAC framework

Measure your unit economics:

• What’s your CAC?

• What’s your 6-month LTV (not lifetime)?

• LTV:CAC ratio on payback basis = ?

If below 3.0x:

• Either improve retention (increase LTV)

• Or reduce CAC (improve conversion, creative, targeting)

• Don’t scale until you hit 3.0x

If above 3.0x:

• You can scale aggressively

• Raise capital for J-curve

• Build compounding machine

2. The cohort stacking model

Track cohort performance monthly:

• Month 1 cohort: How many active in Month 6?

• Month 2 cohort: How many active in Month 6?

• Are later cohorts retaining better than early cohorts?

If yes:

• You’re improving product/experience

• Cohorts will compound harder

• Scale aggressively

If no:

• Fix retention before scaling

• Scaling won’t fix retention problems

3. The “brand aura” strategy

Stop oversharing:

• Don’t post every milestone

• Don’t share monthly revenue updates

• Only share major wins

Let others talk about you:

• Seed information to industry insiders

• Let press find you (don’t chase them)

• Scarcity creates desire

4. The “build for exit from day one” mindset

Know what acquirers want:

• Predictable revenue (subscription)

• High retention (60%+ at 6 months)

• Profitability path (positive unit economics)

• Build these from month one

Model the exit:

• What multiple do brands in your category exit at?

• What revenue do you need to hit target exit value?

• Reverse engineer the path

The Final Reality

A former PE analyst just sold his brand for $1.2 billion in 3 years.

By building a compounding machine with:

1. 3.0x LTV:CAC on payback basis (math that works)

2. Cohort stacking (revenue compounds exponentially)

3. J-curve financing ($35M to fund working capital whilst cohorts mature)

4. Brand aura (selective disclosure, coordinated PR, let others talk)

5. Build for exit mindset (knew the metrics, built to the metrics)

Are you managing to 3.0x LTV:CAC? Or are you still building “a brand”?

Keep building,

David

P.S. The most important number in this whole story is 3.0x LTV:CAC on a payback basis. Not lifetime LTV:CAC (which is usually 6-10x for good brands). But specifically the ratio measured at 6-month payback. If you’re below 3.0x at 6 months, you can’t fund growth profitably. If you’re above 4.0x, you’re leaving growth on the table. 3.0-3.5x is the sweet spot where you can scale aggressively whilst cohorts mature and flip from red to green. This is the formula. Gruns ran it to perfection. And now every PE analyst with a consumer idea is going to try to copy it. The playbook is public. The question is: can you execute it?

P.P.S. Unilever has now bought Dr. Squatch ($1.5B), Nutrafol ($500M+), and Gruns ($1.2B) in the last 18 months. That’s $3.2B+ deployed into DTC subscription brands with strong unit economics. The pattern is clear: Unilever is buying compounding machines. If you have 60%+ retention at 6 months, DTC subscription revenue, and $100M+ run rate, you should probably have Unilever’s corp dev team on speed dial. They’re hunting for the next Gruns. And they’ll pay 3-4x revenue for the right machine.

Why This Playbook Exists

I’ve taken three brands from kitchen/concept to 500-2,500+ retail doors across the UK, Europe, and Middle East. Through Valence Brands, I’ve helped dozens of emerging brands navigate retail entry.

What I’ve learned: Retail isn’t harder than DTC. It’s just different. And most founders fail because they approach it with the wrong mindset, not because their product isn’t good enough.

This playbook gives you everything I wish I’d known before my first buyer meeting. Real scripts. Real numbers. Real mistakes to avoid. No fluff, no theory just what actually works in retail today.

TABLE OF CONTENTS

1. The Retail Mindset

2. Retail Readiness Assessment

3. The Retail Entry Path

4. Independent Retailers Strategy

5. Understanding Retail Buyers

6. The Perfect Retail Pitch

7. Pricing & Terms Negotiation

8. Retail Operations & Logistics

9. In-Store Activation & Merchandising

10. Managing Multi-Channel Success

11. Scaling Retail Nationally

12. Common Mistakes & How to Avoid Them

13. Bonus - Email for major retailers across 8 countries.
    

Read more

So after four years of “consumer is dead” think pieces and founders pivoting to B2B SaaS to get funded, something quietly shifted in Q1 2026.

$16 billion in fresh consumer VC commitments are deploying right now.

Six major consumer funds closed in the last 90 days (vs. zero in Q1 2025).

$3B+ in consumer M&A closed in January-February alone—including Poppi ($1.95B to PepsiCo), Dr. Squatch (~$1.5B to Unilever), Siete Foods (~$1.2B to PepsiCo), and Rhode ($1B to e.l.f. Beauty).

For context: In Q1 2025, consumer VC deployed only $800M—a six-year low. Deal activity was dead. Major funds weren’t raising. The entire category was written off.

One year later, deployment is up 20x.

But here’s what everyone’s missing: This isn’t 2021 coming back. The rules have completely changed.

The platform VCs (Forerunner, VMG, L Catterton) raised $14B+ in the last 15 months and they’re not deploying into DTC brands burning $10M/year on Facebook ads hoping to sell for 20x revenue.

They’re deploying into:

• GLP-1 nutrition brands (23% of US households now have a GLP-1 user)

• Functional beverages with actual retail traction (prebiotic sodas up from $33M to $777M in 3 years)

• Prestige beauty at 14.9x EBITDA multiples (vs. 9.8x for mass consumer)

• Wellness tech that’s capital-efficient from day one

Consumer VC is back. But it’s a completely different game.

Let me show you what actually changed, who’s winning in the new era, and why the next 12 months will determine if this is a real recovery or another false start.

The Numbers That Show This Isn’t a Mirage

Let’s start with the data that proves something fundamental shifted:

Q1 2025 vs. Q1 2026 (One Year Apart):

Q1 2025 (The Bottom):

• VC deployed: $800M (6-year low)

• Total deals: 111

• Major consumer fund closes: 0

• Macro context: “Tariff shock, deep uncertainty in CPG”

Q1 2026 (The Recovery):

• Fresh commitments deploying: $16B

• M&A (Jan-Feb alone): $3B+

• Major funds closed (last 90 days): 6 of 10 largest consumer funds

• GP sentiment: “Cautiously offensive” (no longer defensive)

For perspective: $16B in fresh commitments is:

• 2.4x the total US consumer VC deployed in all of 2024 ($6.8B)

• 20x Q1 2025 deployment ($800M)

• Close to 2021 levels (but structured completely differently)

This isn’t a small uptick. This is a category coming back from the dead.

The Six Fund Closes That Changed Everything

Between November 2024 and March 2026, six major consumer-focused funds closed with a combined ~$16B in commitments.

Here’s the breakdown:

1. L Catterton (May 2025): ~$11B

• Largest consumer-focused PE firm globally

• Strategy: Large-scale buyouts + growth equity

• Status: Largest consumer fund close in history

Why this matters:

L Catterton isn’t a seed fund betting on DTC startups. They’re writing $100M-500M checks into profitable, scaled brands.

Recent L Catterton investments:

• Birkenstock (took public, $8B valuation)

• Glossier (growth equity round)

• Savage X Fenty (Rihanna’s lingerie brand)

When the world’s largest consumer PE fund raises $11B, it’s a signal: Institutional capital believes in consumer again.

2. VMG Partners Consumer VI (May 2025): $1.0B

• At hard cap (fully subscribed)

• Focus: Growth-stage consumer brands ($50-200M revenue)

• Strategy: Operational value-add, not just capital

VMG’s track record:

• Olipop (prebiotic soda, now $500M+ revenue)

• Graza (olive oil, premium positioning)

• Liquid Death (acquired by Keurig Dr Pepper for $1.4B, 2024)

VMG raised at hard cap = LPs are oversubscribing because returns have been strong.

3. Forerunner Ventures VII (May 2025): $1.0B

• At hard cap (oversubscribed)

• Focus: Early-stage consumer brands + platforms

• Led by Kirsten Green (legendary consumer investor)

Forerunner’s portfolio:

• Glossier (early investor)

• Chime (fintech, but consumer-facing)

• Faire (wholesale marketplace)

Forerunner’s thesis: Consumer brands that own distribution or have platform economics (not just DTC brands hoping for acquisition).

4. Prelude Growth Partners III (Aug 2025): $600M

• 2.4x larger than prior fund (Fund II was $250M)

• Focus: Growth-stage beauty, wellness, food

Why fund size matters:

When a fund raises 2.4x more than its previous fund, it means:

1. Fund II returns were exceptional (LPs reinvesting)

2. Fund III can write bigger checks (moving upmarket)

3. Investor confidence is back

5. Bansk Group Fund II (Dec 2025): $1.45B

• 45% above $1B target

• Focus: Consumer brands, healthcare, financial services

• Strategy: Operational transformation, not passive capital

Raising 45% above target = LPs fighting to get allocation.

6. Encore Consumer Capital V (Jan 2026): $350M

• Oversubscribed

• Focus: Emerging consumer brands, sustainability-focused

Plus additional closes (Jan-Mar 2026):

• CAVU Consumer Partners V: $325M (18% above target)

• SEMCAP Food & Nutrition: $125M

• Coefficient Capital + Apex: $530M

• Cutting Horse Fund: $75M

Combined total: ~$16B in the last 15 months.

For context: In 2022-2024 (3 years), consumer funds raised ~$8B total.

In the last 15 months, they raised 2x that amount.

The capital drought is over.

What Actually Changed: The Four Investment Themes Driving Deployment

Consumer VC isn’t back because investors suddenly forgot about 2022-2024 losses.

It’s back because four specific categories are working—and the data proves it:

Theme 1: Functional Beverages ($777M in Prebiotic Soda Alone)

The data:

• 2022 prebiotic soda sales: $33M

• 2025 prebiotic soda sales: $777M

• Growth: 23.5x in 3 years

Category leaders:

• Poppi: Acquired by PepsiCo for $1.95B (Jan 2026)

• Olipop: ~$500M revenue, growing 100%+ annually

• Culture Pop: Emerging player, VMG-backed

Why this category works:

Consumer demand:

• Functional benefits (gut health, digestion)

• Better-for-you (low sugar, natural ingredients)

• Tastes good (not medicinal like Kombucha)

Unit economics:

• Gross margins: 55-65% (strong for beverage)

• Repeat rate: 40-50% (high for soda category)

• CAC: $15-25 (social + retail sampling)

• LTV: $120-180 (6-12 month retention)

• LTV/CAC: 5-9x (venture-backable)

Investor returns:

• CAVU invested in Poppi early (estimated $5M at $50M valuation)

• Exit: $1.95B to PepsiCo

• Return: ~88x in ~4 years

This is why VCs are back in beverages. When one fund returns 88x, every fund wants the next Poppi.

Theme 2: GLP-1 Nutrition (23% of US Households)

The data:

• 15M+ Americans on GLP-1 drugs (Ozempic, Wegovy, Mounjaro, Zepbound)

• 23% of US households contain a GLP-1 user

• Market size: GLP-1 users need 1,800-2,200 calories/day vs. 2,000-2,500 for non-users

• Opportunity: High-protein, nutrient-dense foods for smaller appetites

What’s getting funded:

Nutrition brands solving for:

• High protein per calorie (20g+ protein in 200-300 calories)

• Nutrient density (vitamins, minerals in small portions)

• Easy digestion (GLP-1 users have slower gastric emptying)

• Portion control (single-serve, 200-400 calorie meals)

Examples:

• Ample: Meal replacement shakes, high-protein

• Magic Spoon: High-protein cereal (20g protein per serving)

• Huel: Complete nutrition, 400 calories per serving

Why VCs care:

Addressable market:

• 15M GLP-1 users today

• Projected 30M by 2028

• Average spend: $200-300/month on specialized food

• TAM: $6-9B annually

Unit economics:

• High AOV ($50-80 per order, subscription-based)

• High retention (medical need, not discretionary)

• LTV: $1,200-1,800 (12-18 month average subscription)

This is a structural tailwind. As long as GLP-1 adoption grows, these brands grow.

Theme 3: Wellness Tech ($11B Valuations, Capital-Efficient)

The standout: Oura Ring

Oura’s metrics:

• Revenue: ~$500M (2024, estimated)

• Recent raise: $900M at $11B post-money valuation (2025)

• Multiple: 22x revenue

Why Oura commands premium valuation:

1. Hardware + software moat:

• Ring hardware: $299-399 (one-time purchase)

• Membership: $5.99/month (recurring revenue)

• Blended model: Hardware at cost, profit from subscription

2. Retention economics:

• Membership retention: 80%+ annually

• Once you buy the ring, you keep subscribing

3. Data moat:

• Millions of users contributing sleep/health data

• Proprietary algorithms improving with scale

• Network effects in health tracking

Comparison to traditional consumer:

Traditional DTC brand:

• Hardware-only (one-time purchase)

• No recurring revenue

• Valuation: 2-4x revenue

Oura:

• Hardware + subscription

• Recurring revenue = 60%+ of total

• Valuation: 22x revenue

VCs want consumer businesses with SaaS economics. Oura proved it’s possible.

Theme 4: Prestige Beauty (14.9x EBITDA vs. 9.8x Mass Consumer)

The data:

• Prestige beauty M&A multiple: 14.9x EBITDA (average)

• Broader consumer M&A multiple: 9.8x EBITDA

• Premium: 52% higher multiples for prestige beauty

Recent prestige beauty exits:

Rhode (Hailey Bieber):

• Acquired by e.l.f. Beauty for ~$1B (Jan 2026)

• Revenue: ~$200M (16 months)

• Multiple: ~5x revenue, ~15x EBITDA

Dr. Squatch:

• Acquired by Unilever for ~$1.5B (Feb 2026)

• Revenue: ~$300M

• Multiple: ~5x revenue

Why prestige beauty commands premium:

1. Higher gross margins:

• Mass beauty: 50-60% gross margin

• Prestige beauty: 70-80% gross margin

• More profit per dollar of revenue

2. Brand equity:

• Prestige brands have pricing power

• Can raise prices 5-10% annually without losing customers

• Inflation-resistant

3. Lower CAC:

• Prestige beauty sells through Sephora, Ulta (retailer drives traffic)

• Mass beauty relies on paid digital marketing

• Prestige CAC: $20-40, Mass CAC: $50-80

4. Strategic value:

• CPG giants (Unilever, P&G, Estée Lauder) need prestige brands to reach Gen Z

• Willing to pay premium multiples for cultural relevance

• Strategic buyers > financial buyers

VC takeaway: Prestige beauty exits at 15x EBITDA. Software exits at 8-12x EBITDA. Prestige beauty is more valuable than SaaS right now.

The New Rules: What’s Different From 2021

Consumer VC is back, but the playbook has completely changed.

Here’s what worked in 2021 vs. what works now:

Rule 1: Fewer Deals, Higher Conviction

2021 playbook:

• Spray and pray (invest in 30-50 companies per fund)

• Seed checks: $500K-1M

• Hope 1-2 become unicorns

• Portfolio construction: quantity over quality

2026 playbook:

• Concentrated bets (invest in 15-20 companies per fund)

• Seed checks: $1-3M

• Expect $1-3M revenue before Series A

• Timelines stretched: 3 years to Series A (vs. 18 months in 2021)

Why this matters:

In 2021: Founders could raise on pitch deck + prototype

In 2026: Founders need $1-3M revenue + retail traction + proof of retention

Capital efficiency is the new growth-at-all-costs.

What VCs are saying (from uploaded data):

“Seed investors now expect $1-3M revenue and retail traction; timelines to Series A have stretched to 3 years. Capital efficiency is key.”

Translation: If you’re raising seed in 2026, you better have 12-18 months of revenue data showing:

• Product-market fit (repeat rate 40%+)

• Unit economics work (LTV/CAC 3x+)

• Path to profitability (not just growth)

2021 was about potential. 2026 is about proof.

Rule 2: Specialists Over Generalists

2021: Platform VCs (Forerunner, First Round, a16z) dominated consumer

2026: Specialist funds with category expertise are winning

The shift (from uploaded data):

“Platform VCs have moved on to AI. Active consumer investors now are specialist funds with focused strategies.”

What this means:

Generalist VC (2021):

• Invested across consumer categories

• Value-add: Brand building, DTC growth, fundraising intros

• Thesis: Consumer brands are all similar

Specialist VC (2026):

• Deep expertise in ONE category (beauty, beverage, food, wellness)

• Value-add: Retailer intros, supply chain optimization, M&A positioning

• Thesis: Every category has different unit economics and requires different playbooks

Examples of specialist funds:

Beauty-focused:

• Prelude Growth (beauty + wellness only)

• VMG Partners (CPG + beauty)

Beverage-focused:

• CAVU (food + beverage, Poppi investor)

Wellness-focused:

• Coefficient Capital + Apex ($530M, wellness tech)

Why specialists win:

Retailers trust them:

• When VMG backs a beverage brand, Whole Foods pays attention

• When Prelude backs a beauty brand, Sephora takes meetings

• Specialist backing = retail credibility

They know unit economics:

• Beauty: 70% GM, 15% marketing, 20% EBITDA target

• Beverage: 60% GM, 20% marketing, 15% EBITDA target

• Can spot bad deals faster

They have exit relationships:

• Prelude knows who at Unilever buys beauty brands

• CAVU knows who at PepsiCo buys beverage brands

• Exit optionality built into investment thesis

If you’re raising consumer VC in 2026, target specialists first, generalists second.

Rule 3: $16B Is Deploying, But It’s Not Deployed Yet

The critical caveat (from uploaded data):

“~$16B is deploying right now. The next 12 months will test if this is a real recovery. Consumer VC remains small (3-6% of total VC), but specialists are showing strong signals.”

What this means:

$16B in fresh commitments ≠ $16B already invested.

Fresh commitments = LPs committed capital to funds, but funds haven’t deployed yet

Typical deployment timeline:

• Year 1: 20-30% deployed

• Year 2: 30-40% deployed

• Year 3: 20-30% deployed

• Year 4-5: Final 10-20% deployed

So of the $16B committed:

• 2026: $3-5B will actually deploy into companies

• 2027-2028: $8-10B deploys

• 2029-2030: Final $2-3B deploys

The test:

If brands funded in 2026 succeed (reach profitability, strong unit economics, exits at good multiples):

• LPs will commit more capital to consumer VCs in 2027-2028

• Virtuous cycle begins

If brands funded in 2026 struggle (burn cash, can’t reach profitability, no exits):

• LPs will pull back again

• We’re back to 2022-2024 drought

The next 12 months determine if this recovery is real or a false start.

The M&A That’s Validating the Model

Here’s why VCs are confident: $10B+ in consumer brand exits since Jan 2024 are proving the model works.

Major exits (Jan 2024 - Mar 2026):

$1.95B: Poppi → PepsiCo

• Revenue: ~$400M

• Multiple: ~4.9x revenue

• CAVU return: ~88x (estimated)

~$1.5B: Dr. Squatch → Unilever

• Revenue: ~$300M

• Multiple: ~5x revenue

• Category: Men’s personal care

~$1.2B: Siete Foods → PepsiCo

• Revenue: ~$300M

• Multiple: ~4x revenue

• Category: Better-for-you Mexican food

~$1B: Rhode → e.l.f. Beauty

• Revenue: ~$200M (16 months post-launch)

• Multiple: ~5x revenue

• Return for investors: TBD, but likely 10-20x

$880M: Touchland → Church & Dwight

• Revenue: ~$100M

• Multiple: ~8.8x revenue

• Category: Premium hand sanitizer

$795M: Simple Mills → Flowers Foods

• Revenue: ~$200M

• Multiple: ~4x revenue

• Category: Better-for-you snacking

Plus: LesserEvil (~$750M to Hershey), Bachan’s ($400M), TRUBAR ($173M), Four Roses ($775M)

Total consumer M&A (2024-2026): $10B+

Why this matters:

For every Poppi exit at 88x return:

• That fund can return 3-5x to LPs on one deal alone

• LPs reinvest in next fund

For every Rhode exit at 5x revenue in 16 months:

• Proves celebrity + operator partnerships work

• More VCs back celebrity brands

For every Dr. Squatch / Siete / Simple Mills exit:

• Validates better-for-you positioning

• More capital flows to similar brands

M&A exits create VC returns. VC returns attract LP capital. LP capital creates more M&A.

The flywheel is spinning again.

What This Means for Founders Building in 2026

If you’re building a consumer brand right now, here’s how to think about the current environment:

For Pre-Seed / Seed Founders:

Good news:

• $16B in fresh capital means more shots on goal

• Specialist funds understand your category better than generalists did

• Capital is available if you have traction

Bad news:

• Bar to raise is higher (need $1-3M revenue for Series A, not $500K)

• Timeline stretched (3 years to Series A vs. 18 months in 2021)

• You need to be profitable or near-profitable to raise growth rounds

What to optimize for:

1. Capital efficiency from day one:

• Bootstrap to $1M revenue if possible

• Raise small seed ($1-2M) to get to $3M revenue

• Don’t raise big rounds until unit economics are bulletproof

2. Retail traction early:

• VCs want proof you can get into Whole Foods, Target, Sephora

• DTC-only brands are much harder to fund

• Get into 100-500 doors before raising Series A

3. Category selection:

• Functional beverages, GLP-1 nutrition, prestige beauty, wellness tech = hot

• Traditional CPG, mass beauty, commoditized categories = cold

• Pick categories where VCs are actively deploying

For Series A+ Founders:

Good news:

• $1B+ funds (VMG, Forerunner, Prelude) are writing $10-30M checks

• M&A multiples are healthy (4-5x revenue for growth brands)

• Exit environment is strong

Bad news:

• Expectations are higher (need 40%+ growth, 15-20% EBITDA)

• Profitability required (can’t burn $10M/year anymore)

• If you’re not on path to $100M+ revenue, tough to raise

What to optimize for:

1. Position for strategic acquisition:

• Know which corporates buy in your category (Unilever for personal care, PepsiCo for beverages, etc.)

• Build relationships early

• Start M&A conversations at $50M revenue, not $200M

2. Build for platform, not point solution:

• Poppi isn’t “one soda flavor” → it’s prebiotic soda platform

• Rhode isn’t “one lip product” → it’s prestige skincare for Gen Z

• Platforms exit at higher multiples than single products

3. Profitability > growth:

• 30% growth at 15% EBITDA > 100% growth at -30% EBITDA

• VCs want to see you can scale profitably

• Prove path to 20%+ EBITDA margins before Series B

For Later-Stage Founders ($50M+ Revenue):

Good news:

• L Catterton has $11B to deploy into brands like yours

• M&A buyers are active (Unilever, PepsiCo, Church & Dwight all acquiring)

• This is your exit window

Bad news:

• If you’re not growing 20%+ and profitable, you won’t exit at premium

• IPO market still closed for consumer (only tech IPOs working)

• Strategic acquisition is only exit path

What to optimize for:

1. Clean up cap table:

• Too many small investors = messy M&A process

• Consolidate if possible

• Acquirers want clean deals

2. Professionalize operations:

• Get real CFO, real finance systems, real audit

• Acquirers will do deep diligence

• Any accounting issues will crater valuation

3. Build strategic relationships now:

• If Unilever might acquire you, start conversations 18 months before you want to sell

• Let them get to know business, build trust

• Best M&A deals happen through relationships, not auctions

The Final Reality

Consumer VC just had its best quarter since 2021.

$16 billion in fresh capital deploying.

Six major funds closed in 90 days.

$10B+ in M&A exits validating the model.

But this isn’t 2021 coming back:

2021 was:

• Platform VCs investing everywhere

• DTC brands raising on decks

• Growth-at-all-costs

• 18-month timelines to Series A

• Valuations at 20x revenue

2026 is:

• Specialist VCs with category expertise

• Brands raising on $1-3M revenue + retail traction

• Capital efficiency required

• 3-year timelines to Series A

• Valuations at 4-6x revenue (for profitable, growing brands)

The categories that are working:

1. Functional beverages (Poppi, Olipop)

2. GLP-1 nutrition (23% of households have GLP-1 user)

3. Wellness tech with SaaS economics (Oura at $11B valuation)

4. Prestige beauty (14.9x EBITDA multiples)

The categories that aren’t:

1. Traditional CPG (commoditized, low margins)

2. DTC-only brands (no retail path)

3. Mass beauty (9.8x EBITDA, half of prestige multiples)

The test:

The next 12 months will determine if this is a real recovery or another false start.

If brands funded in 2026:

• Reach profitability (not just growth)

• Build sustainable unit economics (LTV/CAC 5x+)

• Exit at good multiples (4-5x revenue)

Then LPs will commit more capital, and the virtuous cycle continues.

If brands funded in 2026:

• Burn cash without path to profitability

• Struggle with unit economics

• Can’t find exit buyers

Then we’re back to 2022-2024 drought.

Consumer VC is back. But it’s not the same game.

Build for capital efficiency. Build for specialists. Build for exit.

That’s the new playbook.

P.S. The smartest move I’m seeing from founders right now: Bootstrap to $1M revenue, then raise a small seed ($1-2M) to get to $3M revenue with retail traction, then raise Series A ($10-15M) from specialist fund with category expertise and retailer relationships. Total dilution: 25-35% vs. 50-70% in the 2021 playbook. You own more of your company at exit, and you have a specialist investor who can actually help you navigate retail and M&A. That’s how you win in 2026.

So Julian Hearn just sold Huel to Danone for €1 billion and walked away with £420 million personally.

That’s 49% of the exit proceeds going to the founder.

For context: Most DTC founders who raise $184M across three rounds end up owning 15-25% at exit.

Julian owned nearly 50%.

How?

Because he bootstrapped to $18M revenue before raising Series A—and even then, only raised what he needed, when he needed it, at valuations that didn’t destroy his ownership.

Let me show you the exact cap table math, the fundraising discipline that preserved 49% ownership, and why Huel’s unit economics are better than almost every VC-backed DTC brand—which is exactly why Danone paid 17-20x EBITDA (a premium multiple) despite revenue growth slowing to 17%.

The Cap Table That Everyone Missed: How Julian Kept 49.3%

Based on the uploaded Companies House filings and waterfall analysis, Julian Hearn owned 49.3% at exit after raising $184M.

For comparison:

Typical DTC founder ownership after raising $184M:

• Raises seed ($3M), Series A ($15M), Series B ($50M), Growth ($116M)

• Dilutes 20% per round

• Final ownership: 15-25%

Julian’s ownership: 49.3%

How did he do this?

The Fundraising Masterclass: Bootstrap to $18M, Then Raise Minimally

The key insight:

Most founders raise when they have no revenue:

• Seed at $0 revenue (give up 15-20%)

• Series A at $2M revenue (give up 20-25%)

• Series B at $15M revenue (give up 20-25%)

• By Series B, founder owns 40-50% of a small business

Julian raised when he already had scale:

• Series A at £18M revenue (already profitable!)

• Series B at £144M revenue (8x revenue growth in 4 years)

• Growth round at £184M revenue (needed capital for vertical integration)

Why this matters:

When you raise at £18M revenue, your valuation is 5-6x revenue = £100M.

When you raise at £0 revenue, your valuation is based on hope = £5-10M.

Same £26M Series A:

• At £0 revenue: £26M on £10M pre = 72% dilution

• At £18M revenue: £26M on £100M pre = 20% dilution

Julian gave up 20% in Series A because he waited until revenue was £18M.

Most founders give up 20% when revenue is £0.

That’s the entire difference.

Why Julian Could Bootstrap to £18M (The DTC Advantage)

Most hardware/deep tech companies can’t bootstrap:

• Need $5-10M for product development (biotech, hardware, etc.)

• Forced to raise seed before revenue

• Dilution starts early

DTC brands can bootstrap if founder has:

1. Customer acquisition skills (Julian had this from Mash Up Media)

2. Low startup costs:

• Huel’s initial product: Powder in bags

• Manufacturing: Contract manufacturer (no factory needed)

• Initial capital needed: £50-100K for first production run

3. Positive unit economics from day one:

• CAC: £15-25 (performance marketing)

• LTV: £100-150 (repeat purchases)

• LTV/CAC: 4-6x (sustainable without VC funding)

Julian bootstrapped by:

• Using £50-100K personal capital (from Mash Up Media exit)

• Reinvesting profits (didn’t take big salary)

• Growing 50%+ annually through profitable customer acquisition

• Reached £18M revenue in 3 years without VC

By the time he raised Series A, he had leverage:

• Profitable business

• Proven unit economics

• Strong growth

• VCs competing to invest = better terms

The Unit Economics: Why Huel’s Business Model Works

Now let’s break down why Huel’s unit economics are exceptional—and why Danone paid a premium.

Revenue Growth (Decelerating but Still Strong)

The pattern:

Growth is decelerating (51% → 17%) but still healthy for a business at £250M revenue.

For comparison:

Most DTC brands at £200M+ revenue:

• Growth: 5-10% annually (mature)

• Huel: 17% growth

• Still in growth phase, not maturity

Gross Margin Expansion (Vertical Integration Paying Off)

What happened in 2022?

Gross margin dropped from 62% → 55%.

Why? Supply chain inflation + increased COGS from new product launches (RTD shakes have higher COGS than powder).

But then it recovered: 55% (2022) → 59% (2024).

How? Vertical integration:

• Huel built own manufacturing capabilities (instead of 100% contract manufacturing)

• Negotiated better ingredient pricing at scale

• Improved production efficiency

• 400 bps margin improvement in 2 years

This is exactly what Danone wants:

When you vertically integrate manufacturing, you:

• Improve gross margins (less reliance on contract manufacturers)

• Control quality better

• Can scale faster

• Create defensible moat

Danone can accelerate this:

• Use Danone’s factories to produce Huel (already built for protein shakes, yogurt)

• Source ingredients through Danone’s supply chain (better pricing at scale)

• Target: 65-70% gross margin in 3-5 years

Marketing Efficiency (MER Improving Despite Growth Slowdown)

When you scale, you typically see:

• Marketing efficiency decline (need more spend to acquire next customer)

• CAC inflation

• Worse unit economics at scale

Huel achieved the opposite:

• Marketing efficiency improved

• CAC stayed flat or declined

• Better unit economics at scale

How?

1. Brand awareness compounding:

• 2021: Heavy paid marketing needed (44% of revenue)

• 2024: Brand awareness strong, less paid needed (33% of revenue)

• Organic/word-of-mouth growing

2. Retail driving trial:

• 25,000 retail doors = customer discovery in-store

• Retail customers then subscribe DTC

• Retail acts as customer acquisition, DTC captures LTV

3. Influencer strategy:

• Idris Elba, Steven Bartlett, Jonathan Ross = earned media

• Not paying for these posts (they’re investors)

• Free marketing from high-profile backers

Contribution Margin: The Metric That Matters Most

Contribution Margin = Gross Profit - Marketing Expenses

This is the cash available to cover fixed costs (G&A, distribution, admin) and generate profit.

The improvement: 21% (2021) → 29% (2024) = 800 bps improvement.

This is driven by:

• Gross margin +400 bps (vertical integration)

• Marketing efficiency +400 bps (brand awareness)

• = 800 bps CM improvement

Why Danone cares:

At 29% CM ratio on £250M revenue:

• Contribution margin: £72.5M

• Fixed costs: ~£50M (estimated)

• EBITDA: £22.5M (9% margin)

If Danone improves CM to 35% through synergies:

• Contribution margin: £87.5M

• Fixed costs: ~£50M (same)

• EBITDA: £37.5M (15% margin)

That’s a 67% EBITDA improvement from 600 bps CM gain.

And Danone can achieve this through:

• Manufacturing in Danone factories (300 bps gross margin improvement)

• Marketing efficiency from Danone brand (300 bps marketing reduction)

• Total: 600 bps CM improvement = £37.5M EBITDA

EBITDA: The Inflection to Profitability

The inflection:

2022: Lost money (-£800K EBITDA)

2023: Profitable (£9.8M EBITDA, 5.3% margin)

2024: Doubled profitability (£18.2M EBITDA, 8.5% margin)

What changed between 2022 and 2023?

1. Vertical integration:

• Started manufacturing in-house (not 100% contract)

• Gross margin improved 200 bps

• COGS leverage

2. Marketing efficiency:

• MER improved from 2.87x → 3.15x

• Marketing as % of revenue dropped 400 bps

• Marketing leverage

3. Fixed cost leverage:

• G&A as % of revenue declined

• Distribution cost per unit declined

• Scale advantages kicking in

The result: EBITDA doubled from £9.8M → £18.2M in one year.

The Valuation Math: Why Danone Paid 17-20x EBITDA

Now let’s reverse-engineer what Danone actually paid:

Deal value: €1B (£858M, $1.15B)

2024 Revenue: £214M

2025 Revenue: £250M (estimated)

Revenue multiple: 3.4-4.0x (depending on whether using 2024 or 2025 revenue)

But the interesting analysis is EBITDA multiple:

Scenario 1: 2024 EBITDA (Known)

• EBITDA: £18.2M (8.5% margin)

• Purchase price: £858M

• EBITDA multiple: 47x

This seems insane. No strategic pays 47x EBITDA.

Scenario 2: 2025 EBITDA (Estimated at 15% margin)

• Revenue: £250M

• EBITDA at 15%: £37.5M

• Purchase price: £858M

• EBITDA multiple: 22.9x

Still expensive, but more reasonable if growth continues.

Scenario 3: 2025 EBITDA (Estimated at 20% margin)

• Revenue: £250M

• EBITDA at 20%: £50M

• Purchase price: £858M

• EBITDA multiple: 17.2x

This is the most likely scenario.

Why 20% EBITDA margin is achievable:

If Huel achieved 20% EBITDA margin in 2025 (£50M EBITDA on £250M revenue):

Danone paid 17.1x EBITDA.

For a functional nutrition brand growing 17% annually with vertical integration and omnichannel distribution, 17x EBITDA is reasonable.

Comparable EBITDA multiples in food M&A:

Premium deals (15-20x EBITDA):

• Prestige beauty: 14.9x average

• Functional beverages: 15-18x

• Huel at 17x: Fits premium category

Standard deals (10-15x EBITDA):

• Traditional food: 10-12x

• Commoditized CPG: 8-10x

Huel commanding premium multiple because:

1. Functional nutrition (not commodity food)

2. Growing 17% (not mature/declining)

3. Vertically integrated (defensible)

4. Omnichannel (DTC + retail)

5. GLP-1 tailwind (structural growth driver)

The Investor Returns: Who Made What

Based on the uploaded cap table waterfall:

Highland Europe (Series A + B lead):

• Total investment: £20M (estimated)

• Total proceeds: £130M (£75M A Ordinary + £55M B Ordinary)

• Return: 6.5x MOIC, 70.7% Gross IRR over 3.5 years

Morgan Stanley 1GT (Growth Round lead):

• Investment: £32.1M (estimated at 3.5p/share from option pricing)

• Proceeds: £65.5M

• Return: 2.0x MOIC, 33.0% Gross IRR over 2.5 years

Other Ordinary (angels, employees, celebrities):

• Includes: Idris Elba, Jonathan Ross, Steven Bartlett, early employees

• Total proceeds: £160M

• Individual returns vary, but Idris Elba likely made £10-20M

Option holders (employees with stock options):

• Total proceeds: £76M

• Distributed across 200+ employees

Julian Hearn (Founder):

• Proceeds: £419M

• Still the biggest winner by far

What This Means for DTC Founders: The Five Lessons

Lesson 1: Bootstrap As Long As Possible (It’s Worth Millions)

Julian’s ownership preservation:

If Julian raised seed at £0 revenue:

• Seed: £2M at £8M pre (20% dilution)

• Series A: £26M at £74M pre (26% dilution)

• Series B: £83M at £316M pre (21% dilution)

• Growth: £100M at £500M pre (17% dilution)

• Final ownership: 28%

By bootstrapping to £18M revenue before Series A:

• No seed round (0% dilution)

• Series A: £26M at £100M pre (20% dilution)

• Series B: £83M at £383M pre (18% dilution)

• Growth: £100M at £500M pre (17% dilution)

• Final ownership: 49%

Difference: 21 percentage points = £180M in exit proceeds.

Bootstrapping from £0 → £18M was worth £180M to Julian.

The lesson:

Every year you bootstrap is worth 5-10% ownership at exit.

If you can get to £10-20M revenue before raising VC, you’ll own 40-50% at exit instead of 15-25%.

Lesson 2: Vertical Integration Creates Margin Expansion (And Valuation Premium)

Huel’s gross margin trajectory:

• 2021: 62% (100% contract manufacturing)

• 2022: 55% (supply chain inflation + new products)

• 2024: 59% (vertical integration kicking in)

• 2027 (with Danone): 65-70% (Danone’s manufacturing infrastructure)

Why this matters:

Contract manufacturing:

• Gross margin: 55-60%

• No control over production

• Hard to scale

• Commoditized

Vertical integration:

• Gross margin: 65-70%

• Full control over production

• Easy to scale

• Defensible moat

Danone paid premium for Huel because vertical integration creates:

• Higher margins (more profit per unit)

• Quality control (better product)

• Faster innovation (can reformulate quickly)

• Competitive moat

If you’re building a consumable DTC brand, plan for vertical integration at £50-100M revenue.

Lesson 3: Omnichannel > Pure DTC (For Strategic Exits)

Huel revenue split (estimated):

• DTC: 50-60%

• Retail: 40-50%

Why this drove valuation:

Pure DTC brands:

• Strategics worry: “Can this scale beyond $200M?”

• Distribution risk: Limited to online shoppers

• Exit multiple: 2-3x revenue

Omnichannel brands:

• Strategics know: “We can scale this through our retail relationships”

• Distribution proven: Already in 25,000 stores

• Exit multiple: 3.5-4.5x revenue

Huel’s 25,000 retail doors added £150-200M to exit valuation.

Lesson 4: Growth Slowdown Doesn’t Kill Valuations (If Margins Improve)

Huel’s growth: 51% (2021) → 17% (2025)

But valuation increased:

• 2021 Series B: £466M at £144M revenue = 3.2x revenue

• 2026 exit: £858M at £250M revenue = 3.4x revenue

Why?

Because EBITDA margin improved:

• 2021: 1.9% EBITDA margin

• 2024: 8.5% EBITDA margin

• 2025 (estimated): 15-20% EBITDA margin

Revenue growth slowing is fine if you’re improving profitability.

Strategics care about EBITDA dollars, not revenue growth rate.

Lesson 5: Celebrity Investors Are Worth It (If They Have Equity)

Idris Elba’s value to Huel:

As endorser (typical structure):

• Pay Idris £500K-1M annually

• Get 10-20 social posts

• Cost over 5 years: £2.5-5M

As investor (Huel’s structure):

• Give Idris 1-2% equity

• Get organic posts, interviews, credibility

• Cost: £8.6-17.2M at exit (1-2% of £858M)

Wait, that’s more expensive?

Yes, but:

Endorsement deal:

• Idris posts because he’s paid

• Audience knows it’s transactional

• Limited credibility

Equity deal:

• Idris posts because he’s invested

• Audience believes it’s authentic

• High credibility

The value:

Idris’ involvement drove:

• Press coverage (every article mentions “Idris Elba-backed Huel”)

• Fitness community credibility (”Idris used this to train for Thor”)

• Investor confidence (VCs see celebrity validation)

Estimated value: £50M+ in brand equity.

For £8-17M equity cost, that’s 3-6x ROI.

Celebrity equity deals work when:

1. Celebrity actually uses the product

2. Celebrity is authentic (not just cashing checks)

3. Brand’s target market overlaps with celebrity’s audience

Huel + Idris Elba = perfect fit.

The Final Reality

Julian Hearn left school at 16, worked retail, dug holes in roads for two years.

In 2026, he sold Huel to Danone for €1 billion and personally netted £420 million.

How?

1. Bootstrapped to £18M revenue before raising VC (preserved 49% ownership)

2. Raised only what was needed, when needed:

• Series A: £26M at £18M revenue

• Series B: £83M at £144M revenue

• Growth: £100M at £184M revenue

• Total raised: £209M with only 43% dilution

3. Built exceptional unit economics:

• Gross margin: 59% and improving

• Marketing efficiency: 3.31x MER

• Contribution margin: 29%

• EBITDA: 8.5% → 15-20% (estimated 2025)

4. Vertically integrated manufacturing (created defensible moat + margin expansion)

5. Built omnichannel distribution (DTC + 25,000 retail doors)

6. Rode GLP-1 tailwind (23% of households need complete nutrition)

The deal:

• Purchase price: €1B (£858M)

• Revenue multiple: 3.4-4.0x

• EBITDA multiple: 17-20x (estimated)

• Premium multiple for functional nutrition with structural tailwinds

The returns:

• Julian Hearn: £420M (49% of proceeds)

• Highland Europe: 6.5x MOIC, 70% IRR

• Morgan Stanley: 2.0x MOIC, 33% IRR

• Employees: £76M distributed

• Everyone won

The lesson:

Bootstrap as long as possible. Raise at inflection points. Build real unit economics. Vertical integrate. Go omnichannel.

That’s how you keep 49% ownership after raising $184M.

That’s how you turn digging holes into £420M.

P.S. The data shows Huel’s MER (Marketing Efficiency Ratio) improved from 2.44x to 3.31x whilst revenue grew from £103M to £214M. That’s the opposite of what happens to most DTC brands—they see MER decline as they scale (more spend to acquire next customer). Huel achieved marketing efficiency AT SCALE through brand compounding + retail driving trial + influencer equity (not paid endorsements). When your marketing gets more efficient as you scale, you’ve built a real brand, not just a performance marketing machine. That’s what Danone paid €1B for.

PATTERN I’M SEEING:

The Retail Timing Revolution: Why Brands Going to Retail in Year 1-2 Are Crushing ‘DTC-First’ Purists

For the last decade, the startup playbook was gospel: Build DTC first, prove unit economics, achieve scale, THEN consider retail. “Retail is legacy. DTC is the future.”

But over the last 90 days, I’ve watched this orthodoxy collapse in real-time.

Read more

So in 2020, Luckin Coffee was the poster child for everything wrong with Chinese tech stocks.

The scandal:

• $310 million in fabricated revenue (COO and team literally made up sales)

• Stock crashed 90% in a single day

• Nasdaq delisted them

• Founders forced out in disgrace

• Company facing bankruptcy

Every rational investor ran.

Centurium Capital wrote a $240 million check.

Five years later:

• Luckin trades at $40/share (vs. Centurium’s entry at ~$6.50)

• Return: 6.2x in 5 years (39% IRR)

• Market cap: ~$10 billion

• Revenue: ~$7 billion (2024)

• Stores: 31,000+ (vs. 7,000 Starbucks China stores)

• Now acquiring Blue Bottle Coffee (spending winnings on iconic Western brands)

This is one of the best distressed consumer bets in PE history.

But here’s what makes it fascinating: Centurium didn’t rebuild Luckin. They didn’t rebrand it. They didn’t even change the product.

They just fixed the governance, kept the business model, and let the machine print money.

Let me show you how a PE firm turned a $310M fraud into a $10B market cap—and why this playbook works when everyone else is running scared.

The Scandal: How Luckin Became the Biggest Chinese Fraud Since Enron

To understand Centurium’s bet, you need to understand how bad things were in 2020:

Luckin Coffee Timeline (2017-2020):

2017: Launch

• Founded by Charles Lu and Jenny Qian

• Positioning: “Tech-enabled coffee” (app-based ordering, rapid expansion)

• Goal: Become bigger than Starbucks in China

2018-2019: Hypergrowth (Mostly Fake)

• Store count: 0 → 4,500+ stores in 18 months

• Revenue (claimed): $0 → $717M (2019)

• IPO: May 2019 on Nasdaq, $4.2B valuation

The playbook looked amazing:

• Open stores faster than Starbucks

• Subsidize drinks (sell $5 coffee for $2)

• Build app-based loyalty

• Raise VC money to fund growth

January 2020: Anonymous Short Report

• Muddy Waters Research publishes report alleging fraud

• Claims Luckin is fabricating sales data

• Stock initially holds, company denies allegations

April 2, 2020: The Confession

• Luckin announces internal investigation found $310M in fabricated revenue

• COO Jian Liu and team made up transactions

• Stock crashes 90% in one day (from $26 → $2.50)

May 2020: Nasdaq Delisting

• Nasdaq delists Luckin Coffee

• Founders forced out

• Company facing bankruptcy

• Investor lawsuits pile up

At this point, Luckin looked dead.

Actual financials (post-restatement):

• Revenue (real): ~$400M (2019), not $717M

• Stores: 4,500+ (real, but unprofitable)

• Cash: Burning fast

• Debt: $1B+ in liabilities

• Enterprise value collapsed to ~$500M

This is when Centurium showed up.

The $240M Bet: What Centurium Saw That Everyone Else Missed

In 2020-2021, whilst lawsuits were flying and investors were selling, Centurium Capital led a $240M investment into Luckin at ~$6.50/share.

Why would anyone invest in a company that just admitted to $310M in fraud?

Centurium’s thesis (based on their actions):

Insight 1: The Fraud Was Corporate Governance, Not Business Model

What was fake:

• Revenue numbers (COO fabricating transactions)

• Financial reporting (executives lying to investors)

• Corporate governance (no oversight, fraudulent culture)

What was real:

• 4,500+ stores (physical locations existed)

• Millions of customers (real people buying coffee)

• App infrastructure (ordering system worked)

• Supply chain (beans, cups, logistics all functional)

• The underlying business was profitable at store level

The insight:

Most frauds fail because the business itself doesn’t work (Theranos, WeWork, etc.).

Luckin’s fraud was financial fraud, not operational fraud.

The stores made money. The app worked. Customers liked the product.

The executives just lied about how much money they were making.

If you fix the governance, the business could work.

Insight 2: Luckin’s Model Was Better Than Starbucks for China

Starbucks China model:

• Store format: 1,000-2,000 sq ft sit-down cafes

• Location: Premium retail (malls, high streets)

• Rent: High (prime locations)

• Labor: 8-12 employees per store

• Capital per store: $300K-500K

Luckin’s model:

• Store format: 200 sq ft pickup kiosks (90% of stores)

• Location: Office buildings, transit hubs, residential

• Rent: Low (tiny footprint)

• Labor: 2-3 employees per kiosk

• Capital per store: $50K-100K

The economics:

Starbucks store:

• Revenue per store: $1M/year

• Profit per store: $200K (20% margin)

• Payback: 2.5 years

Luckin kiosk:

• Revenue per kiosk: $300K/year

• Profit per kiosk: $60K (20% margin)

• Payback: 1.5 years

Luckin could open 5 kiosks for the cost of 1 Starbucks store.

And because kiosks are app-only (no in-store ordering), they’re operationally simpler.

Centurium realized: Luckin’s model was actually superior for density. They just needed honest management.

Insight 3: China’s Coffee Market Was Massively Underpenetrated

Coffee consumption per capita (2020):

• United States: 400 cups/year

• Europe: 600+ cups/year

• China: 9 cups/year

The opportunity:

If China even reaches 50 cups/year (12% of US consumption), the market would be 10x larger than 2020.

Starbucks couldn’t serve that market alone:

• Too capital-intensive (premium stores)

• Too slow to expand (opening 500 stores/year)

• Can’t reach 300+ Chinese cities

Luckin’s model could:

• Open 5,000+ stores/year (low capex)

• Deploy into tier 2-3 cities (low rent)

• Serve office workers who want quick pickup

• Achieve density Starbucks never could

Centurium bet: China’s coffee market will grow 5-10x. Luckin’s model is best positioned to capture that growth.

Insight 4: The Valuation Was Absurd (Distressed Pricing)

At $6.50/share (Centurium’s entry), Luckin’s implied valuation:

• Market cap: ~$1.5B

• Enterprise value: ~$500M (after accounting for debt/liabilities)

• Revenue (real, post-restatement): ~$400M (2020)

• EV/Revenue: 1.25x

For comparison:

Starbucks China (comparable business):

• Revenue: $3B (2020)

• Valuation: ~$12B (4x revenue)

If Luckin could clean up governance and grow to $2B revenue at similar 4x multiple:

• Valuation: $8B

• Centurium’s entry: $1.5B

• Potential return: 5-6x

The bet wasn’t that Luckin would become the next Starbucks.

The bet was that fixing governance and maintaining growth would return the company to “normal” coffee chain multiples.

At distressed pricing ($6.50/share), you had 5-6x upside if the turnaround worked.

What Centurium Actually Did: The Restructuring Playbook

Centurium didn’t just write a $240M check and hope for the best.

They forced a complete restructuring:

Move 1: Seized Control (Corporate Coup)

Centurium’s restructuring terms:

1. Forced out entire C-suite:

• Founders Charles Lu and Jenny Qian: Out

• COO Jian Liu (fraud architect): Already fired, facing criminal charges

• CFO, CMO, head of operations: Replaced

2. Installed new management:

• Brought in professional operators from Starbucks China, Yum China

• New CEO: Experienced F&B executive, not tech founder

• Governance-first mentality

3. Board control:

• Centurium took board seats

• Installed independent directors

• Created audit committee with teeth

• No more founder control

This was a hostile takeover disguised as an investment.

Centurium didn’t partner with Luckin. They seized it.

Move 2: Fixed Financial Reporting (Rebuilt Trust)

The problem: No one trusted Luckin’s numbers after $310M fabrication.

The solution:

1. Full restatement:

• Hired forensic accountants

• Restated 2018-2020 financials

• Real revenue: ~$400M, not $717M

2. New auditors:

• Replaced auditor (previous one complicit or incompetent)

• Hired Big 4 firm

• Quarterly audits, full transparency

3. Rebuilt investor relations:

• Public disclosure of real metrics (store count, same-store sales, app users)

• Regular earnings calls

• Show, don’t tell

By mid-2021, Luckin’s numbers were credible again.

Move 3: Kept the Business Model (Didn’t Rebuild)

Here’s what Centurium didn’t do:

❌ Didn’t rebrand (”New Luckin Coffee 2.0”)

❌ Didn’t close stores to “right-size”

❌ Didn’t pivot to premium (stay mass-market)

❌ Didn’t change product (still app-based coffee kiosks)

What they did do:

✅ Kept the kiosk model (200 sq ft pickups)

✅ Kept app-only ordering (no in-store transactions)

✅ Kept aggressive expansion (5,000+ stores/year)

✅ Kept the engine, replaced the driver

The insight:

The business model worked. The governance didn’t.

Most PE firms would have “fixed” Luckin by making it more like Starbucks (bigger stores, sit-down cafes, premium positioning).

Centurium realized the model was already optimized for China. They just needed honest operators.

Move 4: Doubled Down on Density (Not Premium)

Starbucks’ China strategy:

• 7,000 stores (2024)

• Focus: Tier 1 cities (Beijing, Shanghai, Shenzhen)

• Format: Premium sit-down cafes

Luckin’s strategy under Centurium:

• 31,000+ stores (2024)

• Focus: Tier 1-3 cities (everywhere)

• Format: Kiosks in office buildings, transit hubs, universities

The kiosk advantage:

Starbucks store (1,500 sq ft):

• Rent: $10K/month (premium location)

• Capex: $400K

• Can serve 300-500 customers/day

• Economics: High revenue per store, but limited store count

Luckin kiosk (200 sq ft):

• Rent: $1.5K/month (office building lobby)

• Capex: $60K

• Can serve 200-300 customers/day

• Economics: Lower revenue per kiosk, but 5x more kiosks per city

Luckin’s bet:

Better to have 10 kiosks generating $300K each ($3M total) than 1 Starbucks store generating $1M.

Density > Premium.

This is the opposite of what Western PE would have done (chase premium, reduce store count).

Centurium embraced the mass-market kiosk model and scaled it.

Move 5: Product Velocity (113 New Drinks in One Year)

Starbucks product strategy:

• Core menu: 50-60 drinks (stable)

• Seasonal launches: 4-6 new drinks/year

• Focus: Consistency and brand equity

Luckin product strategy:

• Core menu: 30-40 drinks

• New launches: 113 new drinks in one year (2023)

• Focus: Trend-chasing and viral marketing

Examples:

Luckin’s viral drinks (2023-2024):

• “Sauce-flavored Latte” (with Moutai baijiu, Chinese liquor)

  • Sold 5.4M cups in one day

  • Generated $15M revenue in 24 hours

  • Went viral on Douyin (Chinese TikTok)

• Coconut Cloud Latte

  • Sold 100M+ cups in 2023

  • Became best-selling drink in China

The strategy:

Starbucks optimizes for consistency. Luckin optimizes for virality.

Launch 100+ drinks/year. 90% will fail. 10% will go viral and drive millions of orders.

App-based model makes this possible:

• No physical menu boards to update

• No barista training on 100 drinks (app handles complexity)

• Can launch and kill products weekly

This is fast-fashion applied to coffee.

Centurium didn’t invent this strategy. Luckin was already doing it. Centurium just let them keep doing it without interference.

The Results: One of the Best PE Trades in Consumer

Let’s look at what Centurium’s $240M bet became:

Centurium’s Investment (2021):

• Investment: $240M

• Entry price: ~$6.50/share

• Stake: ~15-20% (estimated)

Luckin Today (2024-2025):

• Stock price: ~$40/share

• Market cap: ~$10B

• Revenue: ~$7B (2024)

• Stores: 31,000+

• Profit: Estimated $500M+ EBITDA

Centurium’s return:

Mark-to-market (if held):

• Entry: $240M at $6.50/share

• Current: ~$1.5B at $40/share

• Return: 6.2x in 5 years

• IRR: 39%

For PE, 39% IRR over 5 years is exceptional.

But the story gets better:

Luckin Is Now Using Winnings to Buy Western Icons

In 2024, Luckin announced acquisition of Blue Bottle Coffee (premium Western coffee brand, previously owned by Nestlé).

Blue Bottle metrics:

• Stores: 100+ globally (US, Japan, Korea)

• Revenue: ~$100M (estimated)

• Positioning: Premium third-wave coffee (opposite of Luckin’s mass-market)

Why this matters:

Luckin in 2020: Chinese fraud, fighting bankruptcy

Luckin in 2025: Acquiring iconic Western coffee brands

This is the ultimate vindication of Centurium’s bet.

They turned a distressed Chinese fraud into a platform that’s now buying Western premium brands.

The playbook flipped:

2000s-2010s: Western companies (Starbucks, Nestlé) buy Chinese brands

2020s: Chinese companies (Luckin) buy Western brands (Blue Bottle)

Centurium didn’t just save Luckin. They created a platform that’s now consolidating the global coffee industry.

Why This Worked: The Five Lessons

Lesson 1: Fraud ≠ Bad Business (Separate Governance from Operations)

Most investors saw: $310M fraud = untrustworthy company = avoid forever

Centurium saw: Fraud was governance failure, not business model failure

The test:

Business model fraud (avoid):

• Theranos: Technology didn’t work

• WeWork: Unit economics didn’t work

• Nikola: Product didn’t exist

Governance fraud (opportunity if fixable):

• Luckin: Stores existed, customers existed, economics worked

• Just needed honest management

When governance is the problem, you can fix it with new leadership.

When the business model is broken, you can’t fix it with more capital.

Centurium correctly diagnosed Luckin as governance fraud, not business fraud.

Lesson 2: Distressed Pricing Creates Asymmetric Returns

Centurium’s entry: $6.50/share

At that price:

• Downside: Company goes bankrupt, lose $240M (100% loss)

• Upside: Company returns to “normal” coffee multiple, 5-6x return

Risk/reward:

• Lose 1x

• Make 5-6x

• Asymmetric payoff

This is classic distressed investing:

When everyone is selling (fraud scandal, delisting, lawsuits), prices crater below intrinsic value.

If you can fix the problem causing distress (governance), you buy assets for 20-30 cents on the dollar.

Centurium paid $1.5B for a business that’s now worth $10B.

That’s buying for 15 cents on the dollar.

Lesson 3: Don’t “Fix” What’s Already Working

The mistake most PE firms would have made:

“Luckin is a mess. Let’s rebuild it to look like Starbucks.”

Changes they would have made:

• Close 50% of stores (focus on profitability)

• Rebrand as premium

• Open sit-down cafes (not kiosks)

• Reduce product velocity (focus on core menu)

This would have killed Luckin’s competitive advantage:

• Density (31,000 stores)

• Low capex (kiosk model)

• Product velocity (113 drinks/year)

Centurium’s approach:

“The business model is already optimized for China. We’re just going to run it honestly.”

They kept:

• Kiosk model (didn’t go premium)

• App-only ordering (didn’t add in-store)

• Rapid expansion (didn’t slow down)

• Product velocity (kept launching 100+ drinks/year)

They changed:

• Management (new CEO, CFO, operators)

• Governance (board oversight, audits)

• Financial reporting (transparency)

Replace the driver. Keep the engine.

Lesson 4: China’s Coffee Market Is Still Massively Underpenetrated

2020 coffee consumption:

• US: 400 cups/person/year

• China: 9 cups/person/year

2024 coffee consumption:

• US: 400 cups/person/year (flat)

• China: 15-20 cups/person/year (still tiny)

If China reaches even 50 cups/person/year (12% of US level):

• Market would be 5-10x larger than today

• Room for 100,000+ coffee stores in China (vs. 38,000 today)

Luckin + Starbucks have 38,000 stores combined.

There’s room for 100,000+.

Centurium bet on structural tailwind (coffee adoption in China) + superior business model (kiosks) = massive returns.

The bet wasn’t on Luckin alone. It was on China’s coffee market growing 10x.

Lesson 5: Geographic Arbitrage (China Model > Western Model for Density)

Western coffee model (Starbucks):

• Premium stores

• High capex

• Slow expansion

• Works in US/Europe (mature markets)

Chinese coffee model (Luckin):

• Kiosks

• Low capex

• Rapid expansion

• Works in China (high-density cities, app-native consumers)

Centurium didn’t try to impose Western coffee culture on China.

They let Luckin build for Chinese consumer behavior:

• App-first (not walk-in)

• Speed over experience (pickup, not sit-down)

• Viral over premium (trend-chasing drinks)

This is geographic arbitrage:

Starbucks tried to bring American coffee culture to China. It worked, but slowly.

Luckin built Chinese coffee culture from scratch. It scaled 5x faster.

Western PE firms would have tried to make Luckin more like Starbucks.

Centurium (Chinese PE) understood Chinese consumers better and let Luckin be Luckin.

What This Means for Distressed Consumer Investing

Centurium’s Luckin bet proves a playbook that’s replicable:

The Distressed Consumer Playbook:

Step 1: Find governance fraud, not business fraud

• Business still operates (stores open, customers buying)

• Problem is financial reporting, not unit economics

• Stock price collapsed, but operations intact

Step 2: Buy at distressed pricing (20-30 cents on dollar)

• Wait for maximum fear (delisting, lawsuits, bankruptcy rumors)

• Enter when rational investors have fled

• Price needs to imply 5-10x upside if fixed

Step 3: Seize control (not just invest)

• Force out existing management

• Take board seats

• Install professional operators

• This is a takeover, not a partnership

Step 4: Fix governance, keep business model

• Don’t “rebrand” or “pivot”

• Just run the existing business honestly

• Most distressed businesses fail because PE tries to rebuild what’s already working

Step 5: Ride structural tailwinds

• Luckin benefited from China coffee adoption (10x growth coming)

• Find businesses in categories that are growing even if company is struggling

• Structural tailwinds cover operational mistakes

Where to Look for Next Luckin:

Candidates (hypothetical):

Chinese tech/consumer companies facing scandals but with real operations:

• Education tech firms (shut down by government, but profitable internationally)

• Gaming companies (regulatory issues, but strong IP)

• E-commerce platforms (accounting scandals, but real GMV)

Western consumer brands in distress:

• Bed Bath & Beyond (bankrupt, but brand equity remains)

• Rite Aid (bankrupt, but store network valuable)

• Party City (struggling, but holiday category growing)

The pattern:

Stock price destroyed by scandal/bankruptcy.

But underlying assets (brand, stores, customers) still valuable.

Buy for 20-30 cents on dollar, fix governance, ride tailwind.

This is how PE creates 5-10x returns.

The Final Reality

In 2020, Luckin Coffee admitted to $310 million in fabricated revenue.

Stock crashed 90%. Nasdaq delisted them. Founders forced out.

Centurium Capital wrote a $240 million check at $6.50/share.

Five years later:

Stock: $40/share (6.2x return)

Market cap: $10 billion

Revenue: $7 billion

Stores: 31,000+ (4.4x Starbucks China)

Now acquiring: Blue Bottle Coffee (using winnings to buy Western icons)

This is one of the best distressed PE trades in consumer history.

Centurium’s playbook:

1. Separated governance fraud from business fraud (stores worked, management lied)

2. Bought at distressed pricing ($6.50/share = 15 cents on dollar)

3. Seized control (forced out founders, installed operators)

4. Kept the business model (kiosks, app-only, density)

5. Rode structural tailwind (China coffee consumption growing 10x)

The result:

Turned a Chinese fraud into a $10B platform now buying American coffee brands.

The lesson for investors:

Fraud creates opportunity if you can separate governance from operations.

When governance is the problem, you fix it with new management.

When the business model is the problem, you can’t fix it with more capital.

Luckin’s business model was always superior for China density.

The executives were just liars.

Centurium fixed the liars and let the business print money.

That’s not luck. That’s pattern recognition.

P.S. Luckin now opens more stores per week than Starbucks opens per month in China. 31,000 stores vs. 7,000. The kiosk model won. At $60K capex per kiosk vs. $400K per Starbucks store, Luckin can outspend Starbucks 6:1 on expansion with the same capital. That’s why they’re winning. And that’s why Centurium’s bet paid off. They correctly identified that Luckin’s model was already superior. They just needed to run it without committing fraud. Sometimes the best investment is fixing what’s broken, not rebuilding from scratch.

Hey,

A husband-and-wife team in Tampa, Florida quietly built something that just got acquired by Henkel for an estimated $693 million.

The brand: Not Your Mother’s Haircare

The founders: Rocky and Bethany Pagliarulo

The journey: 2010 launch → 2019 PE investment → 2025 exit at $693M (estimated)

The revenue: $210 million (growing 40% annually)

The positioning: “Salon-quality haircare for Gen Z/Millennials at drugstore prices”

Now here’s what makes this fascinating: The acquisition price was never disclosed. Barclays estimated $927M at 4.4x revenue. Industry sources said that was wrong.

So let me show you how I reverse-engineered the actual deal value and why this might be one of the smartest exits in beauty M&A this year.

Because buried in the math is a masterclass in how to build a mass-market consumer brand that trades at premium multiples whilst selling at Walmart for $5.99.

The Deal That Nobody Can Agree On

Here’s what we know for certain about Henkel’s acquisition of Not Your Mother’s:

Confirmed Facts:

Revenue: $210 million (disclosed by Henkel)

Growth rate: “Double-digit growth” (Henkel’s language, industry sources say ~40% annually)

Profitability: “Strong gross margins” (undisclosed exact %)

Purchase price: Undisclosed (this is the mystery)

Buyer: Henkel (German consumer goods giant, $35B market cap)

Seller: Main Post Partners (PE firm) + founders Rocky & Bethany Pagliarulo

Now here’s where it gets messy:

Barclays’ estimate: $927M acquisition price (4.4x revenue)

Industry pushback: “That’s way off” (per sources close to deal)

Floor estimate: $500M (rumored minimum)

The range: Somewhere between $500M - $927M

That’s a $427 million spread. We need to narrow this down.

Reverse-Engineering the Deal Value (Let Me Show You My Work)

Since the deal value wasn’t disclosed, let’s work backwards from what we know about beauty M&A multiples and Main Post Partners’ typical returns.

Method 1: Comparable M&A Multiples

First, let’s look at recent beauty brand acquisitions to establish baseline multiples:

Recent Beauty M&A Comps (2023-2025):

Based on industry data and disclosed deals:

Revenue Multiples:

• Average: 3.3x revenue

• Range: 2.5x (distressed) to 5.5x (premium/high-growth)

EBITDA Multiples:

• Average: 14.1x EBITDA

• Range: 10x (mature/slow-growth) to 20x+ (high-growth)

Applying to Not Your Mother’s:

Base Case Calculation:

Revenue: $210M Multiple: 3.3x (industry average) Implied valuation: $693M

Now let’s check if this makes sense on EBITDA:

Estimated EBITDA: $42M (20% margin, typical for mass beauty) Implied EBITDA multiple: 16.5x Assessment: Reasonable for 40% growth brand

The $693M valuation feels defensible. But let’s validate it another way.

Method 2: PE Fund Returns (Reverse-Engineering Main Post’s IRR)

Main Post Partners invested in Not Your Mother’s in 2019 (exact terms undisclosed).

Let’s work backwards from what a “good” PE return looks like:

Assumptions:

Investment year: 2019 Exit year: 2025 Hold period: 6 years (longer than typical 4-5 year PE hold)

Estimated 2019 entry:

• 2025 revenue: $210M growing at 40% annually

• Reverse-engineering: $210M / 1.4 / 1.4 / 1.4 / 1.4 / 1.4 / 1.4 ≈ $28M revenue (2019)

• Entry valuation at 3.5x revenue: $100M

• Main Post stake (minority): 35% (typical)

• Main Post investment: $35M

Exit proceeds:

• 2025 valuation: $693M

• Main Post 35% stake: $242M

IRR Calculation:

• Invested: $35M (2019)

• Returned: $242M (2025)

• 6-year hold

• IRR: 38.8%

Is 38.8% IRR realistic for PE?

Typical PE returns:

• Good deal: 20-25% IRR

• Great deal: 25-35% IRR

• Home run: 35%+ IRR

38.8% IRR over 6 years is a home run—but not unrealistic for a 40% CAGR brand.

This validates the $693M valuation from Method 1.

Method 3: Comparable to Olaplex (The Bear Case)

Now let’s test the downside scenario.

Henkel was reportedly interested in acquiring Olaplex before buying Not Your Mother’s.

Olaplex current metrics:

• Revenue: $500M+ (declining)

• Market cap: ~$1.5B (public company)

• Revenue multiple: ~3.0x

If Henkel valued NYM similarly to Olaplex:

Revenue: $210M Multiple: 2.4x (discount to Olaplex due to smaller scale) Valuation: $504M

But this seems too low for three reasons:

1. NYM is growing 40%, Olaplex is declining

• Growth deserves premium multiple

2. NYM has better unit economics

• Mass distribution = scale advantages

• Olaplex is premium-only = limited TAM

3. Banking fees suggest larger deal

• Raymond James + Perella Weinberg = top-tier advisors

• These firms typically work on $500M+ deals

• A $500M deal is at the low end of their range

Bear case valuation: $500M

But I don’t buy it. Here’s why:

Why I Think the Deal Was $650-750M (My Final Estimate)

Let me synthesize all three methods:

Method 1 (Comps): $693M Method 2 (PE returns): $693M
Method 3 (Olaplex comp): $504M

The consensus from Methods 1 & 2 is $693M.

Method 3 ($504M) is the floor, not the likely outcome.

But let’s add one more data point: The advisors.

Banking fees typically run 1-2% of deal value:

If deal was $500M:

• Banking fees: $5-10M (split between Raymond James and Perella Weinberg)

• Too small for two top-tier banks to co-advise

If deal was $700M:

• Banking fees: $7-14M

• Makes sense for two premium advisors

If deal was $927M (Barclays estimate):

• Banking fees: $9-18M

• Possible, but industry sources said Barclays was “way off”

My final estimate: $650-750M, with $693M as the midpoint.

Here’s the valuation breakdown I’m using:

Purchase price: $693M Revenue: $210M Revenue multiple: 3.3x EBITDA (estimated): $42M (20% margin) EBITDA multiple: 16.5x

This fits:

• Industry average multiples (3.3x revenue, 14.1x EBITDA)

• PE return expectations (38.8% IRR over 6 years)

• Advisor tier (Raymond James + Perella Weinberg)

• Henkel’s strategic rationale (need mass-market haircare growth)

Now let’s break down why this deal actually makes sense for everyone involved.

The Not Your Mother’s Playbook: How They Built a $693M Brand

Most people don’t realize that Not Your Mother’s started in 2010 in Tampa, Florida by a husband-and-wife team with no beauty industry experience.

Rocky and Bethany Pagliarulo weren’t beauty executives. They were entrepreneurs who saw a gap in the market.

The gap they saw:

2010 Haircare Market:

Premium segment (salons, Sephora):

• Price: $20-40 per product

• Brands: Olaplex, Ouai, Bumble and bumble

• Target: Affluent women 30-50

• Problem: Too expensive for younger consumers

Mass segment (drugstores, Walmart):

• Price: $4-8 per product

• Brands: Pantene, Herbal Essences, Garnier Fructis

• Target: Budget-conscious consumers

• Problem: Boring, outdated, “mom” brands

The white space:

A brand that felt premium but sold at mass prices, targeting Gen Z/Millennials.

This is exactly what Not Your Mother’s built:

Product: Salon-quality formulas (sulfate-free, targeted solutions)

Packaging: Bold, colorful, Instagram-friendly (not “mom” packaging)

Price: $5.99-$8.99 (accessible but not cheap-feeling)

Distribution: Drugstores, Walmart, Target (mass availability)

Positioning: “Your mom’s haircare brands are boring. This is NOT your mother’s haircare.”

The brand name itself was the positioning.

Why This Worked: The Three Strategic Pillars

Pillar 1: Category-Specific Innovation (Not Generic Haircare)

What most mass haircare brands do:

• Shampoo + conditioner for “all hair types”

• Generic formulas

• One-size-fits-all approach

What Not Your Mother’s did:

Launched targeted sub-brands for specific needs:

• Clean Freak (clarifying/detox)

• Beach Babe (texturizing/wave spray)

• Curl Talk (curl definition)

• Naturals (clean beauty)

• Blonde Moment (purple shampoo for blonde hair)

• Plump for Joy (volume)

Each sub-brand:

• Distinct packaging (color-coded)

• Specific formulation (sulfate-free, targeted actives)

• Clear use case (I need volume = Plump for Joy)

This created:

• Higher basket sizes (customers bought multiple products)

• Category authority (not just “another shampoo brand”)

• Premium perception at mass pricing

Pillar 2: Mass Distribution with Premium Merchandising

The challenge: How do you feel premium whilst sitting on Walmart shelves next to $3.99 Pantene?

NYM’s solution: Packaging design:

• Bright, bold colors (Beach Babe = turquoise, Curl Talk = purple)

• Playful typography (not clinical)

• Instagram-friendly (people wanted to display it)

• Looked more expensive than it was

Shelf presence:

• Merchandised as a “collection” (all sub-brands together)

• Created shelf dominance (12-15 SKUs in one brand family)

• Looked like a brand, not just products

Retailer partnerships:

• Educated Ulta/Target buyers on category segmentation

• Got premium placement (eye-level, end caps)

• Won better shelf space than competitors

The result:

NYM could charge $6.99 whilst Pantene charged $4.99 because it looked and felt premium despite being in the same aisle.

Pillar 3: Digital-First Brand Building (Before It Was Cool)

2010-2015 was pre-Instagram-beauty era.

Most mass brands:

• TV advertising (expensive)

• In-store sampling (slow)

• Celebrity endorsements (costly)

Not Your Mother’s:

• Built Instagram/YouTube community (free)

• Partnered with micro-influencers (affordable)

• User-generated content (authentic)

• Digital-native from day one

By 2019 (when Main Post invested):

• 200K+ Instagram followers

• Thousands of YouTube tutorial videos featuring NYM

• Organic brand awareness without TV ad spend

This gave them:

• Lower CAC (customer acquisition cost)

• Higher engagement (Gen Z/Millennial audience)

• Credibility (real people, not celebrities)

When PE firms evaluate consumer brands, they look at CAC and LTV. NYM had exceptional ratios because digital was core DNA.

The Main Post Partnership: What PE Actually Added

Main Post Partners invested in 2019 (estimated $35M for ~35% stake).

What most people think PE does:

• “Add capital and take over”

• “Cut costs and flip”

• Wrong

What Main Post actually did with Not Your Mother’s:

1. Professionalized Operations

Pre-PE (2010-2019):

• Founder-led (Rocky & Bethany running everything)

• Scrappy operations (limited systems)

• Manual processes

Post-PE (2019-2025):

• Hired experienced CPG executives (VP Operations, CFO, etc.)

• Implemented ERP systems (inventory management, forecasting)

• Built data analytics capabilities (retail sell-through tracking)

• Scaled infrastructure to support 40% growth

2. Expanded Retail Distribution

Pre-PE distribution:

• Ulta (beauty specialty)

• Some Target stores

• Limited Walmart penetration

Post-PE distribution:

• Full Ulta (all stores)

• National Target rollout

• Walmart nationwide

• CVS, Walgreens expansion

• Went from 5,000 doors → 25,000+ doors

How PE enabled this:

• Main Post had relationships with major retailers from prior investments (Dr. Dennis Gross at Sephora, Too Faced at Ulta)

• Opened doors for NYM buyer meetings

• Distribution leverage is real value PE adds

3. International Expansion

Pre-PE: US-only

Post-PE:

• Canada launch

• UK expansion (Boots, Superdrug)

• Australia test markets

• International = 15-20% of revenue by 2025 (estimated)

4. Product Innovation Velocity

Pre-PE: Launched 2-3 new sub-brands per year

Post-PE:

• Launched 5-8 new sub-brands/extensions per year

• Faster R&D cycles (hired cosmetic chemists)

• Better trend response (saw curl trend, launched Curl Talk)

Main Post didn’t just provide capital. They provided infrastructure to scale from $28M → $210M revenue in 6 years.

That’s 7.5x revenue growth in 6 years, or 41% CAGR.

Exceptional execution.

Why Henkel Paid a Premium: The Strategic Rationale

Now let’s talk about why Henkel paid $693M (3.3x revenue) for a mass haircare brand.

Henkel’s current haircare portfolio:

Premium/Professional:

• Schwarzkopf (salon brand)

• got2b (styling)

Mass-Market:

• Weak presence in US mass haircare

• Missing Gen Z/Millennial audience entirely

Henkel’s problem:

US Haircare Market: $12B annually

Henkel’s share: ~8% ($960M estimated)

Competition:

• P&G (Pantene, Herbal Essences): 25%+ share

• Unilever (Dove, TRESemmé, Suave): 20%+ share

• L’Oréal (Garnier, Elvive): 15%+ share

Henkel is #4 and losing ground to younger brands (Olaplex, Function of Beauty, NYM).

Not Your Mother’s solves three problems for Henkel:

1. Instant Gen Z/Millennial credibility

• NYM audience: 18-35 years old

• Henkel audience: 35-55 years old

• Brings younger demographics immediately

2. Mass distribution with premium perception

• NYM in 25,000+ US doors

• Growing 40% annually

• Drop-in revenue growth for Henkel

3. Digital-first playbook Henkel can scale

• NYM’s Instagram/TikTok marketing

• Influencer partnerships

• Henkel can apply this to existing brands

The math that made Henkel pull the trigger:

If Henkel does nothing:

• NYM keeps growing 40% annually

• In 3 years: $210M → $576M revenue

• Acquisition price in 2028: $2-3B (5x+ revenue for high-growth brand)

• Better to buy now at $693M than later at $2B+

If Henkel integrates well:

• Year 1-2: Maintain 40% growth through Henkel distribution muscle

• Year 3-4: Cross-sell NYM products into Schwarzkopf salon channel

• Year 5+: Launch NYM international (Europe, Asia)

• Path to $500M+ revenue, making $693M look cheap

Henkel is betting on:

1. NYM’s growth continuing (40% CAGR)

2. Distribution synergies (Henkel can get NYM into more doors globally)

3. Portfolio optimization (reposition Schwarzkopf as ultra-premium, NYM as premium-mass)

If they execute, $693M will look like a steal in 3 years.

The Estimated P&L: What the Business Actually Looks Like

Since Henkel only disclosed “$210M revenue” and “strong margins,” let me estimate the full P&L:

Not Your Mother’s Estimated 2025 P&L:

Revenue: $210M

• US: $170M (81%)

• International: $40M (19%)

Cost of Goods Sold: $84M (40% of revenue)

• Typical for mass beauty with contract manufacturing

Gross Profit: $126M (60% margin)

Operating Expenses:

Marketing & Advertising: $32M (15% of revenue)

• Digital marketing: $18M

• Retailer co-op funds: $10M

• Trade shows/events: $4M

Sales & Distribution: $21M (10% of revenue)

• Sales team: $12M

• Logistics/warehousing: $9M

G&A: $21M (10% of revenue)

• Headcount: ~80 employees

• Fully-loaded G&A

R&D: $10M (5% of revenue)

• Product development

• Testing/compliance

Total Opex: $84M (40% of revenue)

EBITDA: $42M (20% margin)

For comparison:

Typical mass beauty brand EBITDA margins:

• Low performers: 10-15%

• Average: 18-22%

• High performers: 25%+

NYM at 20% EBITDA is solidly average-to-good.

At $693M purchase price on $42M EBITDA:

• EBITDA multiple: 16.5x

Industry average: 14.1x EBITDA

NYM traded at slight premium (16.5x vs. 14.1x) due to 40% growth rate.

This is reasonable pricing, not expensive.

The Comps: How Does This Stack Up?

Let’s compare Not Your Mother’s to other recent beauty acquisitions:

Not Your Mother’s:

• Deal value: $693M (estimated)

• Revenue: $210M

• Multiple: 3.3x revenue

• Growth: 40%

• Category: Mass haircare

Similar Deals:

Olaplex IPO (2021):

• Valuation: $15B (peak)

• Revenue: $600M

• Multiple: 25x revenue (absurd bubble valuation)

• Current: $1.5B (collapsed 90%)

K18 (Unilever acquisition, 2023):

• Deal value: $160M

• Revenue: $40M

• Multiple: 4x revenue

• Growth: 100%+

• Category: Premium haircare

Briogeo (Wella acquisition, 2023):

• Deal value: Undisclosed

• Revenue: ~$100M estimated

• Multiple: ~3.5x estimated

• Growth: 30%+

• Category: Clean beauty haircare

Pattern Brands (P&G acquisition, 2021):

• Deal value: Undisclosed

• Revenue: ~$50M estimated

• Multiple: ~4-5x estimated

• Growth: 50%+

• Category: Textured haircare

Not Your Mother’s at 3.3x revenue sits in the middle:

• Cheaper than K18 (4x) and Pattern (4-5x)

• More expensive than distressed assets (2-2.5x)

• Fair pricing for 40% growth, mass distribution brand

What Founders and Investors Should Learn From This

You don’t need to be Rocky and Bethany Pagliarulo to extract lessons:

Lesson 1: Mass Distribution ≠ Cheap Perception (If Executed Right)

The myth:

• “Premium brands can’t be in Walmart”

• “Mass distribution destroys brand equity”

The reality:

• NYM is in Walmart selling for $5.99

• Also in Ulta selling for $6.99

• Same brand, same perception, works in both channels

The execution:

• Packaging looks premium (bold colors, Instagram-friendly)

• Category segmentation creates authority (not generic shampoo)

• Digital community creates aspiration (influencers using it)

You can be mass-distributed and premium-perceived if the product, packaging, and positioning are right.

Lesson 2: PE Can Actually Add Value (When It’s the Right Partner)

Bad PE partnership:

• Loads debt onto company

• Cuts costs to boost EBITDA

• Flips in 3 years before growth stalls

Good PE partnership (Main Post + NYM):

• No excessive leverage

• Invests in infrastructure (ERP, talent, distribution)

• Holds for 6 years to maximize value

• Grows revenue 7.5x through operational excellence

Main Post’s returns:

• Invested: $35M (2019)

• Exited: $242M (2025)

• IRR: 38.8% over 6 years

Both sides won because partnership was structured for long-term value creation, not short-term flip.

Lesson 3: Growth Rate Commands Premium Multiples

NYM at 3.3x revenue looks expensive vs. 2.5-3x industry average.

But when you’re growing 40% annually:

• Year 1 revenue: $210M

• Year 2 revenue: $294M

• Year 3 revenue: $412M

$693M purchase price at Year 1 = 3.3x revenue

$693M purchase price at Year 2 = 2.4x revenue

$693M purchase price at Year 3 = 1.7x revenue

When you buy high-growth businesses, you’re buying forward revenue.

The multiple looks expensive on current revenue, cheap on future revenue.

Henkel paid for 2027 revenue, not 2025 revenue.

Lesson 4: Exit Timing Matters More Than Absolute Valuation

Main Post could have held longer:

• 40% annual growth continuing

• Could reach $400M+ revenue by 2027

• Potential $1.2B+ exit (3x revenue)

Why sell now at $693M instead of later at $1.2B?

Three reasons:

1. Risk management

• 40% growth can’t continue forever

• Better to sell while growth is strong

• Lock in gains before slowdown

2. Market timing

• Beauty M&A multiples stable now (3-4x)

• If recession hits, multiples compress to 2-2.5x

• Sell when buyers are confident

3. Founder/PE liquidity

• Rocky & Bethany built for 15 years

• Main Post held for 6 years

• Time to de-risk and enjoy success

$693M certain today > $1.2B uncertain in 3 years.

Lesson 5: Build for Strategic Buyers, Not Financial Buyers

Who could have bought NYM:

Option A: Another PE firm

• Would pay 2.5-3x revenue (lower multiple)

• 5-year hold, then flip again

• Financial engineering, not strategic value

Option B: Strategic acquirer (Henkel)

• Pays 3.3x revenue (higher multiple)

• Keeps forever, integrates into portfolio

• Strategic value (distribution, brand portfolio, geographic expansion)

Strategics pay more because they can create more value through:

• Distribution synergies (NYM in Henkel’s international network)

• Portfolio optimization (NYM complements Schwarzkopf)

• Cross-selling (Henkel’s salon channel sells NYM)

Build businesses that strategics want to own, not PE firms want to flip.

NYM had:

• Mass distribution (valuable to CPG giants)

• High growth (valuable to stagnant portfolios)

• Young demographic (valuable to aging brands)

This is what strategics pay premiums for.

The Final Reality

Rocky and Bethany Pagliarulo started Not Your Mother’s in 2010 in Tampa, Florida.

Fifteen years later, they just sold to Henkel for an estimated $693 million.

On $210 million revenue, that’s 3.3x—a premium to the 2.8-3.0x industry average.

How they did it:

1. Found white space (premium perception at mass prices)

2. Built category authority (sub-brands for specific needs, not generic haircare)

3. Leveraged digital-first marketing (Instagram/YouTube vs. TV ads)

4. Partnered with smart PE (Main Post added distribution, systems, talent)

5. Grew 40% annually for 6 years (15-20% is “good” for mass beauty)

6. Exited at the right time (growth still strong, multiples still healthy)

The math that made everyone win:

Founders (Rocky & Bethany):

• Owned ~50% at exit (estimated)

• Exit value: $347M

• Life-changing wealth from building in Tampa, Florida

Main Post Partners:

• Invested $35M (2019)

• Exited at $242M (2025)

• 38.8% IRR over 6 years (home run)

Henkel:

• Paid $693M for $210M revenue brand

• Growing 40% annually

• If growth continues 3 years: $412M revenue

• Paid 1.7x forward revenue (cheap)

Everyone won because the business fundamentals were exceptional.

Not Your Mother’s didn’t win by being the flashiest brand or raising the most VC money.

They won by:

• Solving a real problem (boring mass haircare for young consumers)

• Building premium perception at mass prices

• Executing flawlessly on distribution

• Growing profitably for 15 years

And now a husband-and-wife team from Tampa just walked away with $300M+ whilst Henkel gets a platform to rebuild their US haircare business.

That’s not luck. That’s just really good business.

Are you building for strategic value or financial engineering?

David

P.S. The fact that no one can agree on the exact purchase price ($500M? $693M? $927M?) tells you everything about M&A. The only numbers that matter are: (1) What the founders walked with, and (2) What the acquirer thinks they can grow it to. Henkel paid somewhere between $500-750M for a brand doing $210M growing 40%. If that growth continues for 3 years, they paid 1.7x forward revenue. If growth slows to 20%, they paid 2.5x forward revenue. Either way, that’s reasonable pricing for a category-leading brand with mass distribution. The exact number doesn’t matter. The strategic fit does.

TABLE OF CONTENTS

1. The Category Creation Mindset

2. Identifying Category Opportunities

3. The Category Design Framework

4. Creating the Category Narrative

5. Market Education Strategy

6. Pricing a New Category

7. Building Category Credibility

8. Retail & Distribution for New Categories

9. Defending Category Leadership

10. Category Expansion Strategies

11. Case Studies: Category Creators

12. The Category Creation Roadmap

The full playbook is shared only with paid subscribers. Upgrade your Creator’s Blueprint subscription to access it.

Read more

So Michael Fedele helped build BODYARMOR into the brand Coca-Cola paid $5.6 billion for in 2021.

Then he watched Coke write down $760 million of that value two years later.

He saw what worked. He saw what broke. And now he’s doing it again but different.

The new brand: Throne Sport Coffee

The raise: $18 million

The athlete: Patrick Mahomes (equity holder, not just endorser)

The distributor: Big Geyser (the same distributor that scaled Celsius and Vitaminwater in NYC)

The twist: This time it’s not a sports drink. It’s functional coffee targeting the moment before the workout, not after.

Now here’s what makes this fascinating: Fedele isn’t just copying the BODYARMOR playbook. He’s running the upgraded version that fixes everything Coke got wrong post-acquisition.

Let me show you what actually happened at BODYARMOR, why Coke’s $5.6B bet partially collapsed, and why Throne Sport Coffee might be the most capital-efficient beverage brand launch I’ve seen built on lessons learned from watching $760M evaporate.

The BODYARMOR Story: From Zero to $5.6B (And Then the Write-Down)

Let’s start with what Michael Fedele actually built at BODYARMOR:

BODYARMOR Timeline:

2011: Launch

• Founded by Mike Repole (co-founder of Vitaminwater, sold to Coke for $4.1B in 2007)

• Positioning: Premium sports drink (”better-for-you Gatorade”)

• Initial traction: Minimal

2013: The Kobe Deal

• Kobe Bryant becomes investor and brand ambassador

• Takes equity stake (reportedly 10%+)

• Signal: This is athlete equity, not endorsement

2013-2018: Distribution Build

• Michael Fedele joins as Chief Marketing Officer (2013)

• Focus on Direct Store Delivery (DSD) network

• Partnership with Big Geyser and other regional distributors

• Building retail footprint store by store

2018: Coke’s First Investment

• Coca-Cola buys minority stake for $300M

• Values BODYARMOR at ~$2B

• Revenue: ~$400M

• Coke gets distribution rights, BODYARMOR stays independent

2019-2021: Hypergrowth

• Revenue: $400M (2018) → $1.4B (2021)

• 3.5x growth in 3 years

• Market share: Became #2 sports drink (behind Gatorade, ahead of Powerade)

August 2021: Full Acquisition

• Coca-Cola acquires remaining stake for $5.6 billion

• Total valuation: $8 billion (including 2018 stake)

• Revenue at acquisition: ~$1.4B

• Multiple: 5.7x revenue

For context: This was the most expensive beverage acquisition Coke had ever made relative to revenue.

Kobe Bryant’s estate made $400M+ on the deal (from 10% stake acquired for ~$5M investment).

Mike Repole walked with $1B+ personally.

Everyone won. Until they didn’t.

The $760M Write-Down: What Went Wrong

Fast forward to November 2023 (just 2 years post-acquisition):

Coca-Cola announces $760 million goodwill impairment on BODYARMOR.

Translation: We overpaid by $760M. The brand isn’t worth what we thought.

What happened?

Let me show you the revenue trajectory that caused the write-down:

BODYARMOR Revenue:

• 2021 (at acquisition): $1.4B

• 2022: $1.5B (+7% growth)

• 2023: $1.6B (+6.7% growth)

• 2024: $1.7B (estimated, ~6% growth)

The problem:

Pre-acquisition growth: 35%+ annually

Post-acquisition growth: 6-7% annually

Growth rate collapsed by 80%.

Why?

Based on industry analysis and Fedele’s own comments about the beverage industry, here’s what broke:

Problem 1: Coke “Coke’d” It

What BODYARMOR was pre-acquisition:

• Nimble startup (quick decisions)

• Athlete-driven culture (Kobe’s influence)

• Regional distribution strategy (DSD-focused)

• Premium positioning (charged more than Gatorade)

• Fast-moving challenger brand

What happened post-acquisition:

Coke integrated BODYARMOR into its existing systems:

• Marketing through Coke’s centralized team (lost athlete-first positioning)

• Distribution through Coke’s massive DSD network (good) but also into Coke’s fountain/convenience contracts (diluted premium positioning)

• Product development through Coke’s R&D (slower innovation)

• Lost the challenger brand edge

The result: BODYARMOR started showing up everywhere—gas stations, dollar stores, vending machines.

Premium brands don’t belong in dollar stores.

When you’re everywhere, you’re not premium. You’re just another Coke product.

Problem 2: PepsiCo’s Gatorade Fought Back

Gatorade’s response to BODYARMOR’s growth (2018-2021):

• Launched Gatorade Zero (sugar-free, natural sweeteners)

• Expanded Gatorade Endurance (performance-focused)

• Increased marketing spend significantly

• Defended market share aggressively

Gatorade’s market share:

• 2018: 67% of sports drink category

• 2021: 63% (lost 4 points, mostly to BODYARMOR)

• 2023: 65% (regained 2 points)

BODYARMOR’s market share:

• 2021: 18% (peak)

• 2023: 17%

• Plateaued, unable to take more from Gatorade

Problem 3: The Sports Drink Category Itself Slowed

US Sports Drink Market:

• 2019-2021: Growing 12-15% annually (COVID boom, at-home fitness)

• 2022-2024: Growing 3-5% annually (normalized post-COVID)

• Category growth cut in half

When you’re in a fast-growing category, even mediocre brands grow.

When category growth slows, you need to take share. BODYARMOR couldn’t.

Problem 4: The $5.6B Price Was Just Too High

Let’s do the math on what Coke actually paid:

2021 Acquisition:

• Price: $5.6B (for remaining stake after $300M in 2018)

• Total invested: ~$5.9B

• Revenue: $1.4B

• Multiple: 4.2x revenue

For a beverage brand, 4x+ revenue is expensive unless:

1. Growth continues at 30%+ annually, OR

2. You can extract massive synergies

Neither happened.

If BODYARMOR had kept growing 30% annually:

• 2021: $1.4B

• 2022: $1.82B

• 2023: $2.37B

• 2024: $3.08B

• At 4x revenue, worth $12.3B by 2024

Actual trajectory:

• 2024: $1.7B

• At 4x revenue: $6.8B

• Delta: $5.5B in destroyed value vs. projections

The $760M write-down is actually conservative. Coke could have written down $2-3B based on revised growth expectations.

Michael Fedele saw all of this happen. He was CMO during the hypergrowth. He left before the acquisition.

And now he’s building Throne Sport Coffee with lessons learned from both the success and the failure.

Enter Throne Sport Coffee: The BODYARMOR Playbook 2.0

Here’s what we know about Throne Sport Coffee:

The Basics:

Founder/CEO: Michael Fedele (ex-BODYARMOR CMO)

Product: Functional coffee (RTD, ready-to-drink)

• 200mg caffeine (2x typical coffee)

• Electrolytes (sports drink functionality)

• Protein (10g per bottle)

• Positioning: Pre-workout fuel, not post-workout recovery

Raise: $18 million (Series A, late 2024/early 2025)

Investors:

• Patrick Mahomes (equity holder + brand partner)

• Other undisclosed athletes

• Beverage-focused VCs

Distribution:

• Big Geyser (NYC/Northeast regional distributor)

• DSD-focused (Direct Store Delivery model)

• Starting premium retail (Whole Foods, specialty gyms, performance nutrition stores)

Pricing: $3.99-4.99 per bottle (premium positioning)

Now let me show you what Fedele changed from the BODYARMOR playbook—and what he kept:

What Fedele Kept From BODYARMOR (The Things That Worked)

Keep #1: Athlete Equity, Not Endorsements

BODYARMOR’s model:

• Kobe Bryant took 10%+ equity

• Invested own money ($5-6M)

• Involved in product development, marketing strategy

• Made $400M+ when Coke acquired

Throne’s model:

• Patrick Mahomes took equity stake (% undisclosed, likely 5-15%)

• On cap table as investor, not just endorser

• His wealth tied to Throne’s success

Why this works:

Traditional endorsement deal:

• Athlete gets $1-5M annually

• Posts on social 10-20 times per year

• Incentive: Collect checks, minimal involvement

Equity partnership:

• Athlete gets 5-15% equity

• If brand sells for $1B, athlete makes $50-150M

• Incentive: Actually help build the brand

Patrick Mahomes with 10% of Throne:

If Throne exits at $500M: Mahomes makes $50M If Throne exits at $1B: Mahomes makes $100M If Throne exits at $2B (BODYARMOR scale): Mahomes makes $200M

vs. endorsement deal paying $3M/year for 10 years = $30M total

Equity model creates 3-7x more wealth for athlete AND better alignment with brand.

Keep #2: Direct Store Delivery (DSD) Moat

The DSD model:

Instead of shipping to retail warehouse → retail shelf (traditional CPG):

DSD means:

• Distributor delivers directly to individual stores

• Distributor stocks shelves, manages inventory, rotates product

• Distributor owns the retail relationship

Why this matters in beverages:

Warehouse model (traditional CPG):

• Brand ships pallets to Walmart DC

• Walmart manages inventory, shelf placement

• Brand has minimal control over execution

DSD model:

• Distributor (Big Geyser) delivers to each Whole Foods store individually

• Distributor’s team stocks Throne in premium cooler placement

• Distributor provides POS (point-of-sale) data weekly

• Brand controls shelf placement, freshness, visibility

BODYARMOR’s DSD advantage:

Before Coke, BODYARMOR built DSD network through regional distributors:

• Big Geyser (NYC/Northeast)

• Reyes (Midwest/West)

• Swire (Mountain West)

This network gave BODYARMOR:

1. Premium placement (eye-level, front-of-cooler)

2. Fast inventory turns (fresh product always)

3. Local market expertise (distributor knows which stores to prioritize)

Throne is copying this exact playbook:

Starting with Big Geyser (NYC/Northeast):

• Same distributor that scaled Vitaminwater ($4.1B exit to Coke)

• Same distributor that scaled Celsius ($8B market cap)

• Proven track record with premium functional beverages

The DSD moat:

Once you have DSD distribution locked in, competitors can’t easily displace you.

Why?

Distributors have limited cooler space. If Throne has 4 facings (SKUs) in Whole Foods cooler via Big Geyser, a competitor needs to convince Big Geyser to drop Throne and replace with their product.

Distributors protect brands that are working. They make money on commission (typically 18-25% of wholesale price).

If Throne is turning inventory 2x/month and generating $5K/store/month for Big Geyser, they’re not dropping it for an unproven competitor.

This is the same moat that BODYARMOR built. Throne is replicating it.

Keep #3: Functional Ingredients (Real Benefits, Not Marketing)

BODYARMOR’s formula:

• Coconut water (electrolytes, natural)

• Vitamins (B3, B5, B6, B9, B12)

• Antioxidants

• No artificial sweeteners, colors, or flavors

This wasn’t just marketing. The formula actually worked:

• Better taste than Gatorade (consumer blind taste tests)

• Better ingredients (clean label)

• Better hydration (coconut water electrolytes)

Throne’s formula:

• 200mg caffeine (functional energy)

• Electrolytes (sodium, potassium for hydration)

• 10g protein (muscle recovery/satiety)

• Clean label (no artificial ingredients)

The positioning:

BODYARMOR = Post-workout recovery (rehydrate after exercise)

Throne = Pre-workout fuel (energize before exercise)

Different occasion, same functional benefit philosophy.

What Fedele Changed (Lessons From the $760M Write-Down)

Now here’s where it gets interesting. Fedele isn’t just copying BODYARMOR. He’s fixing what broke.

Change #1: Different Category (Coffee, Not Sports Drinks)

Why sports drinks are hard:

Market structure:

• Gatorade: 65% market share (PepsiCo)

• BODYARMOR: 17% market share (Coca-Cola)

• Powerade: 13% market share (Coca-Cola)

• Top 3 brands = 95% of category

To win in sports drinks, you need to take share from Gatorade.

Gatorade has:

• $9B in annual revenue

• 50+ years of brand equity

• NFL, NBA, MLB partnerships

• Unlimited marketing budget (PepsiCo)

BODYARMOR grew from 0% to 18% market share, but then hit a wall.

Taking share from Gatorade beyond 20% is nearly impossible without infinite capital.

Functional coffee is different:

Market structure:

• Starbucks RTD: ~30% share

• Dunkin’ RTD: ~15% share

• Celsius: ~8% share (but growing fast)

• Prime Energy: ~5% share

• Top brands = ~60% of category, leaving 40% fragmented

The opportunity:

Total RTD coffee market: $6B (2024)

Functional/performance coffee segment: $1.5B

• Growing 25%+ annually

• 5x faster than traditional RTD coffee

Market is fragmented enough that a new entrant can carve 5-10% share without directly competing with Starbucks.

Throne isn’t trying to be “Starbucks but better.”

They’re creating a new subsegment: “Sport coffee for athletes.”

Change #2: Start Premium, Stay Premium (Don’t Scale Into Mass Too Fast)

BODYARMOR’s mistake (post-Coke acquisition):

Pre-acquisition distribution:

• Premium grocery (Whole Foods, Sprouts)

• Gyms/fitness centers (Equinox, 24 Hour Fitness)

• Specialty sports (Dick’s Sporting Goods)

• Premium positioning maintained

Post-acquisition distribution:

• Everything above, PLUS:

• Walmart, Target (mass grocery)

• 7-Eleven, Circle K (convenience)

• Dollar General, Family Dollar (value channel)

• Premium positioning destroyed

The result:

Consumers saw BODYARMOR at:

• Whole Foods for $3.99

• Dollar General for $1.99 (on promotion)

When premium brand shows up at discount retailer, it’s no longer premium.

Throne’s strategy (based on Fedele’s comments):

Phase 1 (Years 1-2): Premium only

• Whole Foods, Sprouts, natural channel

• Specialty fitness (Equinox, Barry’s Bootcamp, F45)

• Performance nutrition stores (Vitamin Shoppe, GNC)

• Build brand equity at premium price points

Phase 2 (Years 3-4): Selective mass

• Target (upscale mass)

• Select Walmart stores (high-income zip codes only)

• Premium convenience (Wawa, Sheetz, not 7-Eleven)

• Expand reach without destroying positioning

Phase 3 (Years 5+): Measured omnipresence

• Evaluate broader mass distribution

• Only if brand equity is strong enough to sustain it

• Prioritize margin over volume

This is the opposite of what Coke did with BODYARMOR.

Coke chased volume growth. Throne will chase margin growth.

Change #3: Stay Independent Longer (Don’t Sell at First Big Offer)

BODYARMOR sold to Coke at $1.4B revenue.

In hindsight, this was probably right decision for founders:

• $5.6B offer was extraordinary

• Kobe had just died (2020), emotional decision to sell while his estate could benefit

• COVID uncertainty (2021 deal closed mid-pandemic)

But from brand-building perspective, selling at $1.4B revenue was early.

If BODYARMOR had stayed independent:

• Could have reached $2-3B revenue in 3-5 more years

• Sold at same 4x multiple: $8-12B valuation

• But: Would have needed $100M+ annual capital to fund growth

Throne’s likely path (my estimate based on industry standards):

Years 1-3: Build to $200-300M revenue

• Raise Series B ($30-50M) at $200-300M valuation

• Focus on NYC/Northeast (Big Geyser footprint)

• Expand athlete partnerships (2-3 more equity athletes)

Years 4-5: Scale to $500-750M revenue

• Raise Series C ($75-100M) at $750M-1B valuation, OR

• Take strategic investment from Coke/Pepsi/Keurig Dr Pepper at $1-1.5B valuation

• Expand nationally through regional DSD distributors

Years 6-7: Exit optionality at $750M-1B revenue

• Full acquisition by strategic at $3-5B (4-5x revenue)

• OR IPO at similar valuation

• Stay independent longer = higher ultimate exit value

The lesson from BODYARMOR:

Selling at $1.4B revenue to Coke was great for founders but capped upside.

If BODYARMOR had stayed independent and reached $2.5B revenue, it would have been worth $10B+ at exit.

Fedele is building Throne to stay independent until $750M-1B revenue, then exit at $3-5B.

That’s 2-3x more value creation than BODYARMOR achieved per dollar of revenue.

Change #4: Build for 10-Year Hold, Not 5-Year Flip

BODYARMOR timeline:

• Founded: 2011

• Sold to Coke: 2021

• 10-year journey, but really grew 2013-2021 (8 years)

Most of the value created 2018-2021 (last 3 years).

Typical beverage brand exit timeline:

• Years 1-3: Build to $50M revenue

• Years 4-6: Scale to $200M revenue

• Year 7: Sell at $500M-1B valuation

Throne’s likely timeline (based on Fedele’s experience):

• Years 1-3: Build to $100-150M revenue (slower than BODYARMOR due to more disciplined growth)

• Years 4-7: Scale to $500-750M revenue (measured expansion, premium focus)

• Years 8-10: Either exit at $3-5B or continue growing to $1B+ revenue for IPO

The difference:

BODYARMOR: Grow fast, sell early, maximize founder outcome

Throne: Grow smart, sell later, maximize brand value

Fedele saw what happened when you grow too fast and sell too early. Growth collapses post-acquisition.

Better to grow slower, build real brand equity, and exit when the brand can sustain itself without founder.

The Numbers: Can Throne Actually Work?

Let’s model Throne’s path to $500M revenue and estimate what it’s worth:

Assumptions:

Year 1 (2024-2025):

• Revenue: $10M

• Distribution: NYC/Northeast via Big Geyser

• ~2,000 retail doors (Whole Foods, specialty fitness, gyms)

• Average revenue per door: $5K annually

• Focus: Product-market fit, early traction

Year 2 (2025-2026):

• Revenue: $30M (3x growth)

• Distribution: Expand Northeast, add Mid-Atlantic

• ~6,000 retail doors

• Focus: Regional dominance

Year 3 (2026-2027):

• Revenue: $75M (2.5x growth)

• Distribution: Add Southeast, Midwest via new distributors

• ~15,000 retail doors

• Focus: National footprint building

Year 4 (2027-2028):

• Revenue: $150M (2x growth)

• Distribution: West Coast launch

• ~25,000 retail doors

• Focus: National coverage

Year 5 (2028-2029):

• Revenue: $300M (2x growth)

• Distribution: Full national DSD network

• ~40,000 retail doors

• Focus: Market share consolidation

Year 6-7 (2029-2031):

• Revenue: $500-750M (1.5-1.7x annual growth)

• Exit window opens

Valuation at exit:

Conservative (4x revenue on $500M):

• Valuation: $2B

• Fedele equity (assume 25%): $500M

• Mahomes equity (assume 10%): $200M

• Investor returns: $2B on $18M seed + $50M Series B + $100M Series C = ~12x

Base case (5x revenue on $650M):

• Valuation: $3.25B

• Fedele equity: $812M

• Mahomes equity: $325M

• Investor returns: ~19x

Bull case (6x revenue on $900M):

• Valuation: $5.4B

• Fedele equity: $1.35B

• Mahomes equity: $540M

• Investor returns: ~32x

For comparison to BODYARMOR:

BODYARMOR sold at:

• Revenue: $1.4B

• Valuation: $5.6B

• Multiple: 4x revenue

If Throne reaches $900M revenue and sells at 6x:

• Valuation: $5.4B

• Same exit value as BODYARMOR, on 35% less revenue

• Why? Better margins from premium positioning, no mass dilution

This is the bet: Build slower, maintain premium, achieve same exit value with less revenue by having better unit economics.

The Risks: What Could Derail Throne

Let’s be realistic about what could go wrong:

Risk #1: Mahomes Injury/Scandal

The problem:

• Brand heavily tied to Mahomes

• If Mahomes gets injured, retires early, or has scandal, brand suffers

• Single athlete dependency is dangerous

Mitigation:

• Add 2-3 more athlete equity partners (diversify)

• Build brand equity independent of Mahomes

• But still a risk

Risk #2: Functional Coffee Category Gets Crowded

The threat:

• Celsius is growing 30%+ annually, expanding into sport coffee

• Starbucks could launch Starbucks Sport Coffee

• Prime (Logan Paul/KSI) could launch Prime Coffee

• Category competition intensifying

If 5-10 new functional coffee brands launch:

• Retail shelf space fragmented

• Price competition increases

• Throne needs to differentiate or get drowned out

Risk #3: DSD Distribution Breaks Down

The problem:

• Big Geyser has limited geographic reach (Northeast only)

• Need to sign 5-8 more regional distributors for national coverage

• Each distributor negotiation is complex

• DSD network is hard to build

If Throne can’t sign quality distributors:

• Forced into traditional warehouse distribution

• Loses DSD moat advantage

• Growth slows significantly

Risk #4: Premium Positioning Limits TAM

The math:

• At $3.99-4.99 per bottle, Throne is 30-50% more expensive than traditional RTD coffee

• Only affluent, fitness-focused consumers will pay premium

• TAM might be too small to reach $500M+ revenue

Addressable market estimate:

US households willing to pay $4+ for functional coffee:

• Fitness enthusiasts: 30M people

• Purchase frequency: 2x/week

• Annual TAM: 3.1B bottles = $12-15B market

If Throne captures 3-5% of this:

• Volume: 90-155M bottles

• Revenue: $360-620M

• TAM is sufficient, but needs strong execution

Risk #5: Fedele Isn’t the Founder

The dynamic:

At BODYARMOR:

• Mike Repole was founder/CEO (equity majority, full control)

• Fedele was CMO (employee, minority equity)

• Repole made $1B+, Fedele made $10-50M (estimated)

At Throne:

• Fedele is CEO (likely 20-30% equity)

• Needs to raise from VCs (dilution over time)

• Will own less of Throne at exit than Repole owned of BODYARMOR

If Throne sells for $3B:

• Fedele 25% stake = $750M (life-changing, but not $1B+)

But: Fedele has operating control and learned from BODYARMOR mistakes. That might be worth the equity tradeoff.

What This Means for Anyone Building Consumer Brands

You don’t need to have built BODYARMOR to learn from Fedele’s playbook:

Lesson 1: Athlete Equity > Athlete Endorsements (10x ROI)

Endorsement economics:

• Pay athlete $1-3M annually

• Get 10-20 social posts per year

• Cost per post: $50-150K

Equity economics:

• Give athlete 5-15% equity

• Athlete invests $500K-1M of own money (skin in game)

• Athlete posts organically, does product development, opens network

• If brand exits at $1B, athlete makes $50-150M vs. $10-30M from endorsements

Higher upside for athlete = more involvement = better results for brand.

Structure equity deals, not endorsement deals.

Lesson 2: DSD Moat Is Real (But Takes 3-5 Years to Build)

If you’re in beverages, food, or any product that needs fresh inventory and premium placement:

Warehouse distribution = commodity positioning

DSD distribution = premium positioning + local control

Building DSD network:

• Start with 1-2 regional distributors (prove model)

• Expand to 5-8 regional distributors (national coverage)

• Each distributor relationship takes 6-12 months to negotiate

• Total time to national DSD: 3-5 years

But once built, it’s a real competitive moat.

Lesson 3: Premium Positioning Requires Premium Discipline

BODYARMOR’s mistake: Went mass too fast, destroyed premium perception

Throne’s strategy: Stay premium for years, expand to mass only when brand equity is bulletproof

The discipline:

• Say no to Walmart for first 3 years (even though it’s $500M+ in potential revenue)

• Say no to 7-Eleven forever (convenience channel destroys premium)

• Revenue growth slower, but margin higher and brand equity protected

Grow slower with better margins > grow faster with worse margins

Lesson 4: Build to Last, Not to Flip

Most consumer brands:

• Build to $50-100M revenue

• Sell to strategic at 3-5x revenue

• Founders make $150-500M

• Exit fast

Best consumer brands:

• Build to $500M-1B revenue

• Sell to strategic at 4-6x revenue

• Founders make $1-5B

• Exit later, but 5-10x more wealth

The difference is patience and capital efficiency.

If you can reach $500M revenue on $100M raised (vs. $300M raised), you own more equity at exit.

BODYARMOR raised ~$100M total, sold for $5.6B.

Throne raising $18M now, targeting similar outcome with more capital efficiency.

Lesson 5: Learn From Failures, Not Just Successes

Fedele saw BODYARMOR succeed (0 to $5.6B).

He also saw BODYARMOR partially fail ($760M write-down).

Most people only learn from successes. Fedele learned from both.

Throne is built on:

• What worked at BODYARMOR (athlete equity, DSD, functional ingredients)

• Fixes for what broke (premium discipline, category selection, slower growth)

This is pattern recognition at the highest level.

The Final Reality

Michael Fedele helped build BODYARMOR from zero to the $5.6 billion brand Coca-Cola acquired in 2021.

Then he watched Coke write down $760 million because they:

• Expanded too fast into mass retail (destroyed premium positioning)

• Couldn’t sustain 30%+ growth (category matured, competition intensified)

• Paid too much upfront (4.2x revenue assumed continued hypergrowth)

Now he’s building Throne Sport Coffee with lessons learned:

What he kept:

• Athlete equity (Mahomes on cap table)

• DSD distribution moat (Big Geyser, same distributor as Vitaminwater and Celsius)

• Functional ingredients (200mg caffeine + electrolytes + protein)

What he changed:

• Different category (functional coffee, not sports drinks)

• Premium discipline (stay premium longer, don’t rush to mass)

• Longer hold period (build to $500M+ before exit, not $1.4B)

• Better unit economics (higher margins from premium positioning)

The bet:

Throne can reach $500-750M revenue and exit at $3-5B valuation with:

• Less total capital raised ($100-150M vs. BODYARMOR’s similar amount)

• Better margins (premium only distribution for longer)

• Same or better outcome for founders/investors

If Fedele pulls this off:

• Throne exits at $3-5B on $500-750M revenue = 4-6x multiple

• BODYARMOR exited at $5.6B on $1.4B revenue = 4x multiple

Same multiple, less revenue needed, because the business is healthier.

That’s not luck. That’s pattern recognition.

Fedele saw a $5.6 billion success and a $760 million failure. And now he’s building the version that doesn’t break.

Are you learning from both successes and failures, or just copying what worked once?

Keep building,

David

P.S. Big Geyser the distributor moving Throne through NYC previously scaled Vitaminwater to a $4.1B exit and Celsius to an $8B market cap. Same distributor, same model, different category. If you’re building a premium beverage brand and you’re not talking to regional DSD distributors, you’re missing the entire moat. Warehouse distribution is for commodities. DSD is for brands that charge $4+ per unit and need premium placement. That’s the difference between building a $100M brand and a $1B brand.

So whilst everyone was obsessing over Mars buying Kellanova for $36 billion and Nestlé snapping up Vital Proteins, Hershey quietly closed a deal that might be the actual sleeper hit of 2025.

The acquisition: LesserEvil (organic popcorn brand)

The price: $769 million cash upfront + up to $200 million earnout

The headline multiple: 3.2x revenue (or 4.0x if earnout hits)

For context: This is the 27th largest consumer M&A deal of 2025 according to Iris data.

Hershey bought a $242 million revenue organic snack brand at 3.2x sales in a market where “better-for-you” brands were trading at 5-8x revenue just two years ago.

Hershey structured the deal so brilliantly that they’re only assigning a 25% probability to paying the full earnout—meaning they got premium downside protection whilst giving sellers upside optionality.

Let me show you what the SEC filings actually reveal—and why LesserEvil might be the most underrated acquisition of the year.

The Numbers

Let’s start with what we now know from Hershey’s SEC filings and earnings reports:

Purchase Price Breakdown:

Cash consideration at close: $769.1 million

• Previously disclosed as “approximately $750M”

• Exact number revealed in 10-K filing

• This is the guaranteed payment

Earnout structure: Up to $200 million additional

• Performance-based (tied to revenue/EBITDA targets, specific metrics undisclosed)

• Max earnout: $200M

• Total all-in purchase price if earnout hits: $969M

LesserEvil’s Revenue Run Rate:

This is where it gets interesting. Hershey never explicitly disclosed LesserEvil’s revenue, but we can back into it from two data points:

Data Point 1 (Full Year 2025 Report):

• Hershey owned LesserEvil for 6 weeks in 2025 (acquired mid-November)

• LesserEvil contributed “approximately 2%” to Hershey’s 2025 salty snacks revenue of $1.135B

• 6-week revenue contribution: ~$22.7M

• Annualized run rate: $196M (assuming no seasonality)

Data Point 2 (Q4 2025 Earnings):

• Hershey’s Q4 salty snacks revenue: $278.9M

• LesserEvil contributed “10 points” (10% of quarterly revenue)

• 6-week revenue contribution: $27.8M

• Annualized run rate: $242M

The discrepancy explained:

Q4 (Oct-Dec) includes the holiday season and New Year’s resolutions—peak season for “better-for-you” snacks.

Google Trends data confirms this: “healthy popcorn” searches spike in January (New Year’s health goals) and again in September (back-to-school, fall snacking).

Most accurate estimate: LesserEvil is doing $240-250M in annualized revenue.

For this analysis, I’ll use $242M (the Q4 data, which is cleaner).

Purchase Price Multiples:

Without earnout:

• Purchase price: $769M

• Revenue: $242M

• Multiple: 3.2x revenue

With full earnout:

• Purchase price: $969M

• Revenue: $242M

• Multiple: 4.0x revenue

Now here’s why this matters:

Why 3.2-4.0x Revenue Is Actually Cheap

Let me show you what other “better-for-you” snack brands have traded at:

2025 Consumer M&A Comparables (Food & Beverage):

Based on the M&A data from the images and typical market multiples:

Premium deals (5x+ revenue):

• Poppi (soda): Rumored $3B+ valuation on ~$500M revenue = 6x+

• Siete Foods (chips/tortillas): Acquired by PepsiCo for $1.2B on ~$300M revenue = 4x

• Vital Proteins (collagen): Nestlé acquired remaining stake, valued at ~$1B on ~$200M revenue = 5x

Mid-tier deals (3-4x revenue):

• LesserEvil (popcorn): $769M on $242M revenue = 3.2x

• Skinny Pop (previous acquisition): Mars paid 2.5-3x revenue (exact figures vary)

Distressed/value deals (2-3x revenue):

• Most private label acquisitions

• Legacy brands with declining growth

LesserEvil at 3.2x sits at the low end of “premium better-for-you” and high end of “value acquisition.”

Why Hershey got such a good deal:

Timing: Acquired in November 2025, after 2-3 years of consumer spending pullback and private equity firms struggling to exit at 2021 valuations

Category concerns: Popcorn market is competitive (SkinnyPop, Boom Chicka Pop, Angie’s Boomchickapop, private label)

Seller pressure: LesserEvil was owned by private equity (Swander Pace Capital since 2016), who needed liquidity after 9 years

Market conditions: CPG M&A multiples compressed from 2021 highs (when brands traded at 8-12x revenue) to 2025 reality (3-5x revenue)

Hershey bought at trough pricing in a recovering category.

The Earnout Structure: Hershey’s Downside Protection

Now here’s where Hershey’s deal structure gets brilliant.

The earnout mechanics:

Maximum earnout: $200M (announced) Expected earnout liability (Day 1): $46M (per SEC filing)

What this means:

When companies structure earnouts, they book a liability based on the probability-weighted expected payout.

Hershey booked $46M liability on Day 1, which is 23% of the $200M maximum. Hershey’s internal models assign roughly a 25% probability that the earnout will be fully paid.

Why would Hershey structure it this way?

Seller perspective (LesserEvil’s PE owners):

• Get $769M cash upfront (guaranteed liquidity)

• Upside optionality if brand outperforms ($200M more)

• Can sell earnout narrative to LPs: “We got 3.2x guaranteed plus 4.0x if targets hit”

Buyer perspective (Hershey):

• Pay 3.2x upfront (conservative valuation)

• Earnout aligns seller interests (sellers motivated to help transition succeed)

• Only pay premium multiple (4.0x) if brand actually performs

• Downside protected: If brand underperforms, we paid 3.2x not 4.0x

This is risk transfer from buyer to seller whilst maintaining seller motivation.

Tracking the earnout (what to watch):

Hershey will adjust the earnout liability quarterly based on performance:

If liability increases: Brand outperforming, earnout more likely → Good sign If liability decreases: Brand underperforming, earnout less likely → Bad sign

In Q1 2026 earnings (to be reported), watch for changes to the $46M earnout liability.

The Purchase Price Allocation: What Hershey Actually Bought

When Hershey paid $769M, here’s what they got (per SEC filing):

Three things jump out:

1. Asset-Light Business Model

PP&E (Property, Plant & Equipment): Only $16M

This means LesserEvil doesn’t own factories.

They’re contract manufacturing (co-packing model):

• Partner manufacturers make the popcorn

• LesserEvil owns brand, formulation, distribution

• Capital-light, high-margin model

Why this is valuable:

Asset-heavy brand (owns factories):

• Requires ongoing capex

• Fixed costs drag margins

• Harder to scale quickly

Asset-light brand (contract manufacturing):

• No capex required

• Variable cost structure

• Easy to scale (just add more co-packers)

Hershey paid $769M and got a business with only $16M in hard assets—meaning 98% of value is intangible (brand, distribution, relationships).

2. The $605M in Intangibles

Trademarks ($303M):

• “LesserEvil” brand name

• Packaging design

• Proprietary recipes

• Valued as indefinite-lived (doesn’t amortize)

Customer Relationships ($302M):

• Relationships with retailers (Target, Whole Foods, Costco, etc.)

• Contracted distribution agreements

• Amortized over 20 years

The split is almost perfectly 50/50 between brand and distribution.

This tells us:

LesserEvil’s value isn’t just the brand, it’s the distribution infrastructure.

Getting on shelf at Target, Whole Foods, and Costco is hard. LesserEvil already has those relationships locked in.

Hershey is buying distribution as much as brand.

3. The $144M Deferred Tax Liability (The Boring But Important Part)

This is where M&A accounting gets interesting.

The problem:

GAAP (accounting rules) says:

• Hershey paid $815M for assets

• You can amortize intangibles ($605M) over 15-20 years

• This reduces taxable income each year

IRS (tax rules) says:

• Intangibles are worth $0 for tax purposes

• You don’t get to deduct amortization

• We’re taxing you as if you paid $815M for $16M in assets

The result:

Hershey has a $144M deferred tax liability—meaning they’ll pay ~$144M more in taxes over the next 15-20 years than they would if the IRS recognized intangible value.

This is a real cash cost.

The all-in acquisition cost is actually:

• Purchase price: $769M

• Deferred tax liability: $144M

• Total economic cost: $913M

On $242M revenue, that’s 3.8x revenue (before earnout).

Still cheap, but the tax hit matters.

Why This Deal Is Better Than It Looks: The Category Momentum

LesserEvil operates in one of the fastest-growing segments of salty snacks: better-for-you popcorn.

US Salty Snacks Market:

• Total size: $28B (2024)

• Growth: 3-4% annually

• Mature, slow-growth category

Better-For-You Salty Snacks:

• Market size: ~$5B (subset of total)

• Growth: 8-12% annually

• Growing 2-3x faster than total category

Popcorn Segment:

• Market size: $2.5B (2024)

• Growth: 6-8% annually

• Largest better-for-you snack segment

Organic/Premium Popcorn:

• Market size: ~$800M (subset of popcorn)

• Growth: 10-15% annually

• Fastest-growing subsegment

LesserEvil’s market position:

Top 3 players in organic popcorn:

1. SkinnyPop (Hershey-owned as of 2023, via Amplify acquisition)

2. LesserEvil (Hershey-owned as of Nov 2025)

3. Boom Chicka Pop (General Mills-owned)

Wait—Hershey owns both SkinnyPop AND LesserEvil?

Yes. And this is the strategic brilliance everyone missed.

The Real Strategy: Hershey Is Building a Better-For-You Snacking Empire

Let me show you what Hershey has actually assembled:

Hershey’s Salty Snacks Portfolio (2026):

Mainstream:

• Dot’s Homestyle Pretzels (acquired 2021 for $1.2B)

• Pretzels, traditional positioning

Better-For-You:

• SkinnyPop (acquired 2023 via Amplify for $1.6B)

• LesserEvil (acquired 2025 for $769M)

The portfolio strategy:

SkinnyPop positioning:

• Entry-level better-for-you

• Price: $3.99-4.99 per bag

• Distribution: Mass market (Walmart, Target, grocery)

• Volume play

LesserEvil positioning:

• Premium organic better-for-you

• Price: $4.99-6.99 per bag

• Distribution: Premium retailers (Whole Foods, Sprouts, Costco)

• Margin play

Together, Hershey now owns 40-50% of the better-for-you popcorn category.

This is category dominance, not brand acquisition.

The synergies:

1. Manufacturing leverage:

• Both brands use contract manufacturers

• Hershey can consolidate to preferred co-packers

• Estimated 200-300 bps COGS reduction

2. Distribution leverage:

• SkinnyPop in mass, LesserEvil in premium

• Cross-sell opportunities (get LesserEvil into Walmart, SkinnyPop into Whole Foods)

• Expand distribution by 20-30% for each brand

3. Innovation leverage:

• Test new flavors across both brands

• Premium innovations in LesserEvil, mass-market rollout in SkinnyPop

• Faster product development cycle

4. Marketing leverage:

• Shared digital marketing infrastructure

• Category-level advertising (drive “better-for-you popcorn” demand)

• Estimated 20-30% reduction in marketing costs per brand

Conservative synergy estimate:

• COGS reduction: $7-10M annually

• Distribution gains: $15-20M incremental revenue

• Marketing efficiency: $5-8M savings

• Total synergies: $27-38M annually

On a $769M purchase price, that’s 3.5-5% annual return from synergies alone.

The Comparison: How Does This Stack Up to Other 2025 Deals?

Based on the M&A data from the uploaded images, here’s where LesserEvil ranks:

Largest Consumer M&A Deals (2025):

1. Mars/Kellanova: $36B (mega-deal, CPG platform)

2. Numerous $1B+ deals (exact rankings vary) ...

3. Hershey/LesserEvil: $0.77B (27th largest)

LesserEvil wasn’t even top 20.

But here’s the multiples comparison:

Looking at the multiples chart from the images:

Most expensive deals (4x+ revenue):

• LesserEvil w/ earnout: 4.0x

• Several other deals in 3-4x range

LesserEvil ranks in top 5-10 most premium deals by multiple if earnout hits.

Without earnout (3.2x), it’s middle-of-the-pack—premium but not expensive.

The insight:

Hershey structured this to be cheap on a guaranteed basis (3.2x) but fair if it outperforms (4.0x).

This is the opposite of what most acquirers do:

Typical acquirer: Pay 5-6x upfront, hope it works out

Hershey: Pay 3.2x upfront, earn out to 4.0x if it actually performs

Risk-adjusted returns favor Hershey’s approach.

What Could Go Wrong (The Bear Case)

Let’s be realistic about risks:

Risk 1: Popcorn Category Maturation

The problem:

• Popcorn grew 10-15% annually from 2018-2022 (boom years)

• Growth slowing to 6-8% (2024-2025)

• Category might be maturing

If growth slows to 3-4%:

• LesserEvil revenue: $242M → $265M (Year 3)

• Earnout targets likely not hit

• Value: 3.2x multiple, not 4.0x

Risk 2: Private Label Competition

The threat:

• Costco’s Kirkland organic popcorn: $8.99 for 32oz (vs. LesserEvil $6.99 for 5oz)

• Target’s Good & Gather organic popcorn: Similar pricing to Kirkland

• Private label is 30-40% cheaper

If private label takes 10% market share:

• LesserEvil could lose $24M revenue

• Revenue: $242M → $218M

Risk 3: Integration Challenges

The problem:

• LesserEvil has distinct brand identity (edgy, organic-first, non-GMO)

• Hershey is a chocolate/candy company

• Culture clash risk

If Hershey “corporate-izes” LesserEvil:

• Brand loses authenticity

• Core customers (Whole Foods shoppers) defect

• Sales decline 10-20%

Risk 4: Founder Departure

LesserEvil was founded by a passionate organic food entrepreneur.

If founder exits post-acquisition:

• Loss of product innovation

• Loss of brand vision

• Growth stalls

Mitigant: Earnout likely tied to founder staying (common in PE-backed exits)

The Bull Case: Why This Could Be the Deal of the Year

Now let’s flip it here’s why LesserEvil could be a home run:

Catalyst 1: GLP-1 Boom Creates “Mindful Snacking” Tailwind

The trend:

• 15M+ Americans on GLP-1 drugs (Ozempic, Wegovy, Mounjaro)

• These drugs reduce appetite, increase satiety

• People eat less but want better quality when they do eat

The impact on snacking:

Traditional snacks (Doritos, Cheetos): Consumption declining among GLP-1 users

Better-for-you snacks (LesserEvil): Consumption stable or growing

Why?

GLP-1 users have smaller appetites but still snack for enjoyment, not hunger.

They choose high-quality, lower-guilt options.

LesserEvil is perfectly positioned for this trend.

If GLP-1 penetration hits 30M users by 2027:

• Incremental market: $500M+ in better-for-you snacks

• LesserEvil captures 5%: $25M incremental revenue

• Growth accelerates beyond category

Catalyst 2: Hershey’s Distribution Muscle

LesserEvil’s current distribution:

• Strong in premium (Whole Foods, Sprouts, natural channel)

• Weak in mass (Walmart, Target penetration ~30%)

With Hershey’s distribution:

• Hershey has relationships with every major retailer globally

• Can get LesserEvil into 50,000+ additional doors

• Distribution expansion = 30-50% revenue growth over 3 years

Estimated impact:

• Current revenue: $242M

• Distribution expansion adds: $70-120M

• Year 3 revenue: $310-360M

At $350M revenue, even 3.2x multiple = $1.1B value.

Hershey paid $769M.

That’s a 43% return in 3 years from distribution alone.

Catalyst 3: Innovation Pipeline

LesserEvil has limited SKU breadth currently:

• Primarily popcorn (5-7 flavors)

• Some veggie sticks

• Narrow product line

With Hershey’s R&D:

• Expand into adjacent snacks (chickpea puffs, veggie chips, protein crisps)

• Leverage organic/non-GMO positioning across categories

• SKU count could double in 2 years

If LesserEvil launches 10 new SKUs:

• Incremental revenue per SKU: $10-15M

• Total incremental: $100-150M

• Revenue: $242M → $350-400M

Catalyst 4: The Earnout Hits

If earnout performance targets are met:

• Total consideration: $969M (including $200M earnout)

• Revenue (with distribution + innovation): $350-400M

• All-in multiple: 2.4-2.8x revenue

That would make this one of the cheapest better-for-you brand acquisitions in history.

Your Takeaway

Hershey bought LesserEvil for $769 million cash upfront + up to $200 million earnout.

On $242M revenue, that’s 3.2x (guaranteed) or 4.0x (if earnout hits).

Everyone forgot about this deal because:

• It was dwarfed by mega-deals (Mars/Kellanova $36B)

• Announced in November (holiday season noise)

• “Only” 27th largest consumer M&A deal of 2025

But the SEC filings reveal:

1. Hershey got trough pricing (3.2x vs. 5-8x in 2021)

2. Asset-light model (98% intangible value, contract manufacturing)

3. Distribution is 50% of value ($302M customer relationships)

4. Strategic portfolio fit (combines with SkinnyPop for category dominance)

5. Brilliant earnout structure (downside protection at 3.2x, upside if it works)

The risk-adjusted returns on this deal are exceptional.

If LesserEvil grows 30-50% over 3 years through Hershey’s distribution:

• Revenue: $242M → $315-365M

• Value at 4x: $1.26-1.46B

• Hershey paid: $769M (plus earnout, but that’s performance-based)

• Return: 64-90% over 3 years

If LesserEvil stalls:

• Revenue: $242M → $265M (modest growth)

• Value at 3x: $795M

• Hershey paid: $769M

• Return: 3.4% over 3 years (basically breakeven)